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AIM AND OUTLINE OF THE THESIS
Biocatalysis is increasing in popularity compared to chemical ap-
proaches to produce the most diverse chemical components. This 
popularity is often the consequence of the lower environmental im-
pact and/or of the selectivity of biocatalysts. Despite this, to compete 
with chemical processes, biocatalysts must fulfill many requirements. 
Therefore, there is a strong demand for stable, fast, and easy to pro-
duce biocatalysts. The research described in this thesis focused on the 
exploration of new or engineered redox enzymes that can be used for 
selective alcohol oxidations or ketone reductions. 
In Chapter 1 an important oxidative biocatalysts family is described, 
the flavin-dependent oxidases. Flavoprotein oxidases represent a 
relevant group of biocatalysts that are already used in many differ-
ent applications. Based on structural features, different subclasses 
of FAD- or FMN-containing oxidases can be identified. The chapter 
discusses the use of these oxidases in biotechnological applications. 
Particular attention is given to glucose oxidase, cholesterol oxidase, 
(hydroxymethyl)-furfural oxidase (HMFO) and methanol oxidase. 
In Chapter 2 the protagonist is HMFO. This flavoprotein oxidase is a 
key enzyme in the quest for a new process to produce a bio-based plas-
tic, an eco-friendly alternative to petrol-based plastic. In this chapter it 
is shown that an engineered HMFO can be used to efficiently produce 
furandicarboxylic acid (FDCA). The work performed in this chapter 
involved the use of the computational FRESCO method to predict 
stabilizing mutations. By combining a number of identified benefi-
cial mutations, a highly stable HMFO variant was engineered which 
displays an improved thermostability and high catalytic performance. 
It brings this flavoprotein oxidase closer to industrial applications. 
Chapter 3 follows the trend of optimizing HMFO for industrial appli-
cation. The two goals of this study were to improve the yield of heter-
ologous expression and to explore a non-traditional immobilization 
of HMFO. Secretion of the expressed enzyme using P. pastoris and 
immobilization of the biocatalyst on the spore surface of B. subtilis rep-
resent two ways to try to improve HMFO production and application. 
These two methods aimed at facilitating downstream processing of 
enzyme production (purification of secreted or immobilized enzyme) 
and its ease of use in conversions (conversion performed in media 
containing secreted enzyme or recycling of the immobilized enzyme). 
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In Chapter 4 the attention is turned to a newly characterized alcohol 
oxidase. An alcohol oxidase (AOX) from a white-rot fungus was studied 
for its substrate tolerance. This revealed that the oxidase can be used 
for a large number of alcohols. Perhaps the most intriguing finding 
was its ability to oxidize diols into hydroxyacids. The ability to convert 
alcohols into acids renders AOX an attractive biocatalyst for selective 
alcohol oxidations.
Finally, Chapter 5 represents an explorative study on the use of deaza-
flavoenzymes as biocatalysts. Knowledge regarding F420-dependent 
enzymes and their biocatalytic potential is limited mainly due to the 
low commercial availability of the cofactor. The research described in 
this chapter pursued two main goals. First, it was explored whether 
a F420-dependent alcohol dehydrogenase can be used for the enanti-
oselective reduction of prochiral ketones. Gratifyingly, the studied 
alcohol dehydrogenase was found to perform such enantioselective 
reductions. The second target was to provide a cost-effective cofactor 
regeneration system which was achieved by varying the utilized co-
factor, the cosubstrate and the cofactor regeneration enzyme.
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Biocatalytic oxidations have attracted the interest of academic and 
industrial research since many decades [1]. The ability to carry out oxi-
dations with high enantioselectivity together with the broad substrate 
scope and mild reaction conditions render enzymes attractive, envi-
ronmentally sustainable catalysts [2]. Redox reactions are performed 
by peroxidases, oxidases, oxygenases, reductases and dehydrogenases. 
Such enzymes can be used to produce for example: alcohols, aldehydes, 
ketones and carboxylic acids that may be problematic to obtain in a 
single step via traditional chemical approaches. Oxidative biocatalysts 
employ various mechanisms that involve a variety of different electron 
acceptors, electron donors and/or redox cofactors. Common redox 
cofactors are metals (e.g. iron or copper), heme cofactors, nicotinamide 
cofactors (NADH and NADPH), and flavin cofactors (FAD and FMN). 
Typical electron acceptors/donors are small redox-active proteins (such 
as cytochrome C), nicotinamide coenzymes, cosubstrates, molecular 
oxygen and hydrogen peroxide [3].
An oxidase is defined as an oxidoreductase that utilizes molecular 
oxygen (O2) as electron acceptor [4]. In contrast to oxygenases, reduc-
tases, and dehydrogenases, oxidases are of major interest because 
they do not depend on coenzymes (such as nicotinamide cofactors 
or quinones) that need to be regenerated, but rely only on molecular 
oxygen as electron acceptor. Their ability to work without any coen-
zyme regeneration make them cost-effective and less complicated, 
and therefore more suitable for industrial applications [5]. In contrast 
to other redox enzymes, such as dehydrogenases, oxidases are not 
very abundant in nature [6]. This is probably due to the fact that in 
most cases oxidases catalyze the reduction of dioxygen into hydrogen 
peroxide. This means that the electrons generated through the oxida-
tion of an organic substrate are irreversibly lost and cannot be used 
in metabolic route. Moreover, the typical byproduct of the reaction, 
hydrogen peroxide, is a reactive and toxic molecule. In some cases, 
reduction of dioxygen can even lead to more damaging reactive oxygen 
species, such as superoxide. Only in a few oxidases, such as some 
reported NADH oxidases, reduction of dioxygen into harmless water is 
accomplished. Oxidases can be subdivided in two major groups based 
on the employed cofactor: copper- and flavin-containing oxidases [6].
In this chapter we focus on the flavin-containing oxidases. Many 
members of the flavoprotein oxidase family are regarded as valuable 
tools for biotechnological applications. Flavoprotein oxidases often are 
highly selective (for a particular substrate or exhibiting high enantio- 
or chemoselectivity), display a high activity, do not rely on any metals, 
ABSTRACT
This chapter represents a journey through flavoprotein oxidases. 
The purpose is to excite the reader curiosity regarding this class of 
enzymes by showing their diverse applications. We start with a brief 
overview on oxidases to then introduce flavoprotein oxidases and 
elaborate on the flavin cofactors, their redox and spectroscopic char-
acteristics, and their role in the catalytic mechanism. The six major 
flavoprotein oxidase families will be described, giving examples of 
their importance in biology and their biotechnological uses. Specific 
attention will be given to a few selected flavoprotein oxidases that are 
not extensively discussed in other chapters of this book. Glucose ox-
idase, cholesterol oxidase, 5-(hydroxymethyl)furfural (HMF) oxidase 
and methanol oxidase are four examples of oxidases belonging to the 
GMC-like flavoprotein oxidase family and that have been shown to 
be valuable biocatalysts. Their structural and mechanistic features 
and recent enzyme engineering will be discussed in details. Finally, 
we give a look at the current trend in research and conclude with a 
future outlook.
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or hydroquinone) [13]. The flavin absorption spectra in the oxidized 
state in water exhibit four distinct peaks at around 445, 375, 265, and 
220 nm, with extinction coefficients above 104 M−1 cm−1 [14]. The absor-
bance spectra of 1- and 2-electron reduced flavins are totally different, 
with the fully reduced flavins exhibiting very little absorbance in 
the visible range. While the direct protein environment around a 
protein-bound flavin can affect UV/Vis absorbance features to a small 
extent, the fluorescence of flavin cofactors in proteins is typically 
influenced to a large extent. The neutral forms of oxidized flavins 
exhibit an intense yellow-green fluorescence at around 520 nm [14]. 
The polypeptide chain and especially certain amino acids (tryptophan 
and tyrosine) are potent quenchers of flavin fluorescence [13] [15]. 
The effect of the protein on flavin fluorescence is often exploited for 
biochemical studies of flavoenzymes. For example, the ThermoFAD 
assay has been developed that allows an easy way of determining 
the apparent melting temperature (thermostability) of flavoproteins. 
It relies on detecting the difference in flavin fluorescence upon un-
folding a (purified) flavoprotein using a temperature gradient, which 
is typically performed by using a real-time PCR machine [16]. The 
protein amount and assay time required for this assay are minimal 
and it can be used in a high-throughput fashion [16]. It is the ideal 
system to evaluate libraries of variants in thermostability studies. The 
assay is so sensitive that, if the flavoenzyme is well expressed, it can 
be performed using cell-free extracts [17].
The redox potentials for the two-electron reductions of FAD and 
FMN free in solution at pH 7.0 are respectively -219 mV and -205 mV 
[18] [19]. In aqueous solution the flavin cofactor can be found in three 
different redox states: the oxidized redox state, the flavin semiqui-
none (one-electron reduced), or the fully reduced state (two-electron 
reduced) (Scheme 1).
The catalytic cycle of flavoenzymes typically comprises of two half-re-
actions. In the reductive half-reaction the oxidized flavin is reduced 
by its first substrate. In the second half-reaction, the reduced flavin 
is reoxidized. In the case of flavoprotein oxidases, molecular oxygen 
is able to act as efficient electron acceptor in the latter oxidative half- 
reaction (Scheme 2). The ability to swiftly react with molecular oxygen, 
to reduce it to hydrogen peroxide, sets flavoprotein oxidases apart from 
other flavoproteins [20]. The exact details on how molecular oxygen is 
converted into hydrogen peroxide, with the concomitant reoxidation 
of the flavin cofactor, are still not well understood. It is thought that the 
first step of the reaction involves the generation of a superoxide anion 
and flavin semiquinone [21]. In a second electron transfer process, 
hydrogen peroxide is generated along with fully oxidized flavin. The 
and require no expensive coenzymes or cosubstrates. These features 
make them good candidates for various biotechnological applications, 
for synthesis of high value compounds[7] or biosensors [8]. 
FLAVIN COFACTORS
Flavin-containing oxidases contain flavin mononucleotide (FMN) or 
flavin adenine dinucleotide (FAD) as redox cofactor (Figure 1). In only 
a few cases, flavoprotein oxidases contain one or more additional 
cofactors [9]. FAD and FMN are synthetized starting from riboflavin 
(vitamin B2). Phosphorylation of riboflavin by action of riboflavin 
kinase results in FMN. Adenylation of FMN yields FAD, the most com-
mon flavin cofactor in flavoenzymes [10].
The majority of flavin-containing enzymes, using either FAD or FMN, 
contain a tightly non-covalently bound flavin. In a relatively small 
number of flavoproteins, the flavin cofactor is covalently bound. In 
most cases, this involves a covalent tethering of the protein to the 
benzyl moiety of a FAD cofactor. For some covalent flavoproteins, 
the role of such covalent linkage has been shown to be essential to 
increase the redox potential of the flavin cofactor, to allow oxidations 
of compounds that are difficult to oxidize. In other cases, the covalent 
attachment may serve other purposes such as allowing enzymes to 
adopt a relatively open active site, increase the stability or protecting 
the protein from proteolysis [11] [12]. 
The spectroscopic characteristics of riboflavin, FAD and FMN are 
comparable. This is mainly due to the shared isoalloxazine core struc-
ture [13]. The variability in the UV/Vis absorption spectra depend 
largely on the oxidation state of the flavin (quinone, semiquinone 
Figure 1 Structures of riboflavin, FMN and FAD. The enzymes involved in the syn-
thesis of FMN and FAD are also indicated. 
Riboflavin FMN FAD
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rate-limiting step is thought to be the first electron transfer (from the 
fully reduced flavin to O2) [22].
FLAVOPROTEIN OXIDASES FAMILY
Based on sequence and structure similarity, the majority of flavopro-
tein oxidases have been classified in six distinct flavoprotein families 
[6]. The structural diversity is illustrated in Figure 2 which shows 
the structures of representative oxidases from all six flavoprotein 
families. Here, we provide an overview for each class focusing on 
the biotechnological applications of these enzymes. This includes a 
more detailed description of recent findings and engineering efforts 
concerning two representatives of the GMC-family: methanol oxidase 
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Scheme 2 Catalytic cycle of the flavin cofactor in flavoprotein oxidases.





Flavoprotein oxidases family 
 
Based on sequence and structure similarity, the majority of flavoprotein 
oxidases have been classified in six distinct flavoprotein families [6]. The 
structural diversity is illustrated in Figure 2 which shows the structures of 
representative oxidases from all six flavoprotein families. Here, we provide an 
overview for each class focusing on the biotechnological applications of these 
enzymes. This includes a more detailed description of recent findings and 
engineering efforts concerning two representatives of the GMC-family: 
methanol oxidase and HMF oxidase.  
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The VAO-type oxidase family 
 
The vanillyl alcohol oxidase from the fungi Penicillium simplicissimum (EC 
1.1.3.38) (VAO) could be regarded as the founder of the VAO-type oxidase 
family [23]. This enzyme has been extensively characterized from a biochemistry 
point of view [24] [25]. Several studies report on the engineering of VAO to 
clarify the amino acids involved in catalysis and their role in (covalent) FAD 
binding [26] [27]. A relatively large number of VAO-type oxidases contain a 
covalently bound FAD, usually tethered to a histidine residue, in a conserved 
FAD-binding domain (FAD_binding_4 domain, Pfam01565) [28]. Members of 
this family have been found to be able to produce a variety of high-value 
aromatic compounds [29]. As the name suggests, VAO can oxidize vanillyl 
alcohol (4-hydroxy-3-methoxybenzyl alcohol) to vanillin (4-hydroxy-3-methoxy 
benzaldehyde), but it is also active on plant-derived allylic phenols such as 
chavicol and eugenol. Remarkably it is also able to stereoselectively convert 
catecholamines to hydroxylate alkylphenols [24] [30]. More recently another 
member of the VAO family was discovered and characterized: eugenol oxidase 
from the bacterium Rhodococcus sp. strain RHA1 [31]. This oxidase is also active 
towards vanillyl alcohol, but displays a higher efficiency for eugenol, converting 
it into coniferyl alcohol. The high levels of heterologous expression of eugenol 
L-Lactate oxidase from Aerococcus viridans 
PDB:2DU2 
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members contain a covalently bound FAD. However, in these cases 
the linkage typically involves a cysteinyl bond, not a histidyl bond. 
Amine oxidases can be grouped according to their substrate scope: 
amino acids, polyamines, monoamines and methylated lysines. 
D-Amino acid oxidases (DAAO) (EC 1.4.3.3) are flavoenzymes that 
oxidize with excellent stereoselectivity natural D-amino acids. The 
oxidation of D-amino acids results in the formation of imino acids 
that spontaneously hydrolyze into to the corresponding α-keto acids 
and ammonia [38]. D-amino acid oxidase from Rhodotorula gracilis is 
of great biotechnological interest because it can be employed for the 
industrial synthesis of cephalosporins. This DAAO oxidizes cephalo-
sporin C to α-keto adipil-7-ACA, which is an important intermediate 
for the synthesis of semisynthetic cephalosporins [39]. L-Amino acid 
oxidases (LAAO) (EC 1.4.3.2) catalyze the oxidative deamination of 
L-amino acids to the corresponding α-keto acids [40]. Snake venom 
is rich of L-amino acid oxidases that are subject of many studies and 
attracted biotechnology interest because they participate in apoptosis 
induction, cytotoxicity, induction and/or inhibition of platelet aggre-
gation, hemolysis, as well as antiparasitic and have anti-HIV activities 
[41] [42]. Recently, an LAAO with antimicrobial activity was discovered 
from a marine microorganism which may be a relevant finding in 
the context of the urgent quest for new antibiotics [43]. DAAOs and 
LAAOs are employed also in deracemization of α-amino acids and 
in biosensors [44] [45] [46]. Polyamine oxidases play a role in the 
catabolism of spermine and spermidine and their acetyl derivatives. 
They are fundamental for cell growth and a deregulated metabolic 
pathways of polyamine oxidases can cause cancer [47] [48]. Mono-
amine oxidase (MAO) A and B are located on the outer mitochondrial 
membrane and oxidize primary, secondary, and tertiary amines as well 
as several neurotransmitters, to the corresponding imines [49]. MAO 
inhibitors have been used for the treatment of depression and neuro-
degenerative diseases as Parkinson’s disease and Alzheimer’s disease 
[50]. A fungal MAO has been developed into a valuable biocatalyst 
for the preparation of enantiopure amines [51]. The last subgroup of 
amine oxidases is constituted by the lysine-specific demethylase. An 
eminent member of this group is the lysine-specific demethylase 1 
(LSD1) (EC 1.14.11.B1) which is fundamental in epigenetic regulation 
of gene expression in cells, modulating cellular activities including 
growth and differentiation [37]. LSD1 catalyzes the oxidation of the 
carbon-nitrogen bond between the methyl group and the epsilon 
amine of the lysine. The result is the demethylation of the lysine 
residues in the N-terminal of histone H3 and the tumor suppressor 
protein p53. An uncontrolled expression of LSD1 has been correlated 
THE VAO-TYPE OXIDASE FAMILY
The vanillyl alcohol oxidase from the fungi Penicillium simplicissimum 
(EC 1.1.3.38) (VAO) could be regarded as the founder of the VAO-type 
oxidase family [23]. This enzyme has been extensively characterized 
from a biochemistry point of view [24] [25]. Several studies report 
on the engineering of VAO to clarify the amino acids involved in 
catalysis and their role in (covalent) FAD binding [26] [27]. A relatively 
large number of VAO-type oxidases contain a covalently bound FAD, 
usually tethered to a histidine residue, in a conserved FAD-binding 
domain (FAD_binding_4 domain, Pfam01565) [28]. Members of this 
family have been found to be able to produce a variety of high-value 
aromatic compounds [29]. As the name suggests, VAO can oxidize 
vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) to vanillin 
(4- hydroxy-3-methoxy benzaldehyde), but it is also active on plant- 
derived allylic phenols such as chavicol and eugenol. Remarkably it 
is also able to stereoselectively convert catecholamines to hydroxylate 
 alkylphenols [24] [30]. More recently another member of the VAO 
family was discovered and characterized: eugenol oxidase from the 
bacterium Rhodococcus sp. strain RHA1 [31]. This oxidase is also active 
towards vanillyl alcohol, but displays a higher efficiency for eugenol, 
converting it into coniferyl alcohol. The high levels of heterologous 
expression of eugenol oxidase and the robustness stimulated further 
studies related to its structural properties and to explore the biocat-
alytic scope [32] [33] [34]. In 2005, Huang and coworkers discovered 
the first VAO-type oxidase that contain a covalent FAD attached by 
two covalent bonds: via 6-S-cysteinyl- and 8α-N1-histidyl bonds [35]. 
This oxidase from the fungus Acremonium strictum is active on glu-
cooligosaccharides (EC 1.1.99.B3). More recently also other FAD-con-
taining oxidases, presenting the same bicovalent FAD-linkage has 
been discovered [36]. It has been hypothesized that the FAD cofactor, 
anchored by two covalent bonds, may allow such enzymes to evolve a 
moderately open active site. Enzymes that contain bicovalently bound 
FAD typically act on relatively bulky substrates like oligosaccharides 
and secondary metabolites [35]. Moreover, the two covalent FAD- 
linkages increase the flavin redox potential resulting in the highest 
redox potentials measured for flavoproteins which allows them to 
catalyze demanding reactions [12].
THE AMINE OXIDASE FAMILY
This family of flavoprotein oxidases includes enzymes able to oxidize 
primary and secondary amines, as well as polyamines and amino 
acids [6] [37]. All amine oxidases have a similar N-terminal domain 
that assures binding of FAD. As observed for the VAO family, some 
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employed to produce adipic acid which is a platform chemical for the 
synthesis of for example nylons and resins [72]. Another example of 
an acyl-CoA oxidase-type is the fungal nitroalkane oxidase (NAO) 
(EC 1.7.3.1) isolated from Fusarium oxysporum grown in a medium 
containing nitroethane [73]. NAO catalyzes the oxidation of neutral 
nitroalkanes to the corresponding aldehydes or ketones, releasing 
nitrite [74].
THE 2-HYDROXYACID OXIDASE FAMILY
Members of this family have conserved common structural motifs 
and typically contain FMN as flavin cofactor. Examples of oxidases 
belonging to the 2-hydroxyacid oxidase (HAO) family are L-lactate 
monooxygenase[75] and glycolate oxidase  [76]. HAOs present a β8/
α8 TIM barrel structure and have a conserved arginine in the active 
site [75]. Plants possess HAOs with different specificities for medium- 
and long-chain hydroxyacids. These enzymes are involved in fatty 
acid and protein catabolism as well as in plant photorespiration like 
the glycolate oxidases (EC 1.1.3.15) [77]. HAO has been found also in 
mammals. They share a similar structure to the plant HAOs and they 
are also active on glycolate and 2-hydroxy fatty acids [78]. Glycolate 
oxidase from spinach has been used for kinetic resolution of racemates 
to produce different R-2-hydroxy acids [79]. L-lactate-oxidase (EC 
1.1.3.2) was exploited to obtain D-lactate from racemic lactate which 
is a valuable starting material for manufacturing chiral compounds 
[80]. Lately Faber and co-workers designed a biocatalytic oxidative 
cascade employing a (S)-specific α-hydroxyacid oxidase from Aero-
coccus viridans for the conversion of fatty acids into α-ketoacids [81]. 
Remarkably, among the members of this family, another nitroalkane 
oxidase from Streptomyces ansochromogenes (EC 1.7.3.1) was identified. 
Like the above mentioned acyl-CoA oxidase-type NAO, it can oxidize 
primary nitroalkanes to aldehydes or ketones [82]. 
THE GMC-TYPE OXIDASE FAMILY
At the beginning of 90s the glucose-methanol-choline oxidoreductase 
protein family (GMC) was identified [83]. These enzymes can oxidize 
a broad variety of substrates maintaining an overall conserved N- 
terminal GMC_oxred_N domain (Pfam 00732) which has a role in 
FAD binding [84]. The C-terminal region is less conserved because it 
is involved in substrate binding. Nevertheless, an active site histidine 
is usually conserved because it is involved in the catalytic mechanism 
of substrate oxidation and FAD reoxidation [85] [86]. Members of 
the GMC family typically contain a dissociable FAD cofactor and 
oxidize a broad range of primary and secondary alcohols, forming 
with various cancers, playing an important role in differentiation 
and self-renewal of tumor cells, therefore inhibition of LSD1 could 
be employed as anticancer measure [52] [53]. 
THE SULFHYDRYL OXIDASE FAMILY 
Enzymes belonging to this family catalyze the pairing of cysteine thiols 
into disulfide bonds [54]. These oxidases are characterized by an all-α 
fold where the isoalloxazine ring is positioned in a helix bundle and the 
flavin cofactor is never covalently bound [55]. Two main sub-families 
can be recognized: Erv-like (Pfam04777) and Ero-like (Pfam04137). Erv-
like sulfhydryl oxidases are present in different cellular compartments, 
for example in the mitochondrial intermembrane space and in the 
endoplasmic reticulum (ER) [56]. They have been also found in viral 
genomes where they are suspected to be implicated in the oxidative 
folding of viral proteins and in the assembly of viral particles [57]. 
Ero-like oxidases are found only in the ER where they form disulfide 
bonds in newly synthetized proteins [54]. Sulfhydryl oxidases (SOXs) 
are interesting from a biotechnological viewpoint, and several patents 
have been filed in very different fields. Many applications concern 
the food industry ranging from dairy and baked products to flavours 
control [58] [59] [60]. In the baking industry they might be employed 
to improve the strength of the dough. This effect is due to the oxida-
tion of low-molecular weight thiols which avoids the formations of 
thiol-disulfide bonds that depolymerize the gluten proteins, reducing 
the dough elasticity [61]. There are speculations also on potential use 
of SOXs in dyes, detergents and in cosmetics for hair treatments [62] 
[63]. SOXs could also be employed in biosensors, for the detection of 
glutathione, or determination of sulfhydryl content and amino acids 
concentration [64] [65] [66]. SOXs also find industrial applications 
regarding formation of disulfide bonds in recombinant proteins in 
large scale protein production [67]. 
THE ACYL-COA OXIDASE-TYPE OXIDASE FAMILY
Acyl-CoA oxidase (ACO) (EC 1.3.3.6) is the representative model of 
this family [68]. This FAD-containing oxidase catalyzes the Cα-Cβ 
oxidation of fatty acids and is active on CoA derivatives of fatty acids 
with aliphatic chains from 8 to 18 carbons [69]. Structural studies have 
revealed that the N-terminal domain is constituted of only α-helices 
(Pfam02771) and the enzyme has a middle domain formed by a β- 
barrel (Pfam02770), and a C-terminal domain of α-helices (Pfam00441) 
[70]. Lately an ACO from Arabidopsis thaliana was employed for the 
synthesis of an atypical polyketide extender unit in a one-pot reaction 
[71]. ACO was recently expressed in an engineered yeast strain and 
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which the FAD is covalently linked belongs to the VAO family [103]. 
CHOX has been found in several microorganisms and has a role in the 
initial step of cholesterol metabolism or, in pathogens, it helps to alter 
the physical structure of the cell membrane [104]. As in the case of 
GOX, also for this oxidase there are numerous applications with great 
commercial value. Regarding the biosensing field, similarly as GOX, 
immobilized CHOX can be used in biosensors to detect cholesterol 
in food samples, blood serum and other clinical samples [105]. This 
enzyme finds applications also in the production of steroids, such 
as 4-androstene-3, 17-dione (AD) and 1,4-androstadiene-3,17-dione 
(ADD) which are important starting chemicals for anabolic drugs 
and contraceptive hormones synthesis [106] [107]. Due to its original 
role in pathogens CHOX is also used in biomedical applications to 
treat bacterial infections because of its ability to damage the cell 
membrane [108]. It can be used also for agriculture purposes thanks 
to its insecticidal effect against the larvae Anthonomus grandis [109].
HMF OXIDASE
HMF oxidase (HMFO) (EC 1.1.3.47) represents a good example of the 
multipurpose potential of flavin-dependent oxidases. HMFO was only 
recently discovered and quickly became popular for its ability of oxidiz-
ing HMF. It can accept also many others industrially relevant chemicals 
such as vanillyl alcohol and furans [88]. The interest in HMFO mainly 
lays in the fact that the fully oxidized product of HMF, 2,5-furandicar-
boxylic acid (FDCA), is considered as a versatile bio-based chemical 
building block. By being able to convert HMF into FDCA, polymers can 
be made using renewable material as HMF can be prepared from carbo-
hydrates [110] [111] [112]. HMF and 2,5-furandicarboxylic acid (FDCA) 
are furan compounds, which were listed as the top 10 value-added 
bio-based products by the US Department of Energy [111]. FDCA has 
applications with high commercial value especially in the polymer 
field because it can potentially substitute terephthalic, isophthalic, and 
adipic acids in the manufacture of polyamides, polyesters, and poly-
urethanes [113]. Its versatility as building block made it the best candi-
date for renewable polyester synthesis such as polyethylene furanoate 
(PEF). PEF is breaking into the petroleum-based PET supremacy as 
competitive technology thanks to its similar if not superior structural 
properties. Current chemical methods to synthetize FDCA rely on high 
temperature and high pressure and expensive or toxic chemicals [114]. 
Therefore, biocatalytic approaches with their mild operational condi-
tions would represent a greener approach to obtain FDCA. Among the 
biocatalytic approaches to produce FDCA from HMF it is possible to 
distinguish four categories: lipase-based, multienzymatic cascades, 
the corresponding aldehydes or ketones. In some rare cases they are 
also capable to further oxidize the aldehyde moiety into the respective 
carboxylic acid [87] [88] [89]. Over the years the catalytic mechanism 
has been debated, but the current consensus is that it involves a 
hydride transfer mechanism regardless of the type of alcohol [90]. 
The reaction is likely to start with proton abstraction from the hy-
droxyl group of the substrate by the conserved active site histidine. 
GMC oxidoreductases from fungal sources find many applications 
in biosensors [91] and in the food industry  [92]. Some fungal GMC 
enzymes are employed in biomass valorization, as these oxidases are 
involved in lignocellulose degradation [93]. GMC-type FAD-containing 
oxidases, like most other flavoprotein oxidases, produce hydrogen 
peroxide as a byproduct which can inactivate the oxidase or other 
biocatalysts. This can be a major drawback of using such oxidases for 
bulk chemicals production [94]. Catalase (EC 1.11.1.6) can be coupled in 
oxidation reaction as it has a high activity and can easily decompose 
H2O2 to oxygen and water [95].
Many GMC-type oxidases have been extensively studied, but the 
most representative member of this family is glucose oxidase (GOX) 
(EC 1.1.3.4). GOX is considered as the “Ferrari” of oxidases with an 
astonishing kcat/KM (O2) of 1.5X106 M-1 s-1. It catalyzes the oxidation of 
β-D-glucose to D-glucono-δ-lactone producing H2O2 [96] [86]. Glucose 
oxidase is an enzyme produced by fungi and insects, its main natural 
roles are related to the production of hydrogen peroxide [92]. For exam-
ple, GOX is secreted by honey bees in honey to act as anti-bacterial [97]. 
Penicillium chrysogenum glucose oxidase has been studied to evaluate 
its anti-fungal effect and for possible application as antimicrobial for 
disinfection of medical devices [98]. This extraordinary oxidase has 
countless applications in the food industry. In the baking industry GOX 
could be employed to improve bread’s texture as alternative to potas-
sium bromate which could be cancerogenic [99]. It can also be used 
to improve food shelf-life thanks to the ability to oxidize glucose and 
reduce the effects of Maillard reaction, or as oxygen scavenger [100] 
[101]. Already 30 years ago GOX was recognized as an “ideal enzyme” 
for biosensors applications thanks to stability and other factors [102]. 
Thanks to the high glucose specificity in presence of other sugars, for 
many years GOX has dominated the field, but now thanks to protein 
engineering more enzymes are making their way [8].
Another well-known GMC-type flavoprotein oxidase is cholesterol 
oxidase (CHOX) (EC 1.1.3.6). CHOX is a FAD-containing oxidase able 
to catalyze the oxidation of cholesterol to its 3-keto-4-ene deriva-
tive, cholestenone. Cholesterol oxidases with the FAD cofactor non- 
covalently bound and are part of the GMC family, while CHOX in 
28 CHAPTER 1: The Multipurpose Family of Flavoprotein Oxidases Introduction 29
1
while the V367R boosted the activity on FFCA by promoting proper 
positioning of the substrate [120]. As a next step in improving the 
biocatalytic performance of HMFO for FDCA production, engineering 
was performed to increase its stability. For this, the FRESCO method 
(Framework for Rapid Enzyme Stabilization by COmputational librar-
ies) was employed. FRESCO is a computational approach that allows 
to computationally predict, using the crystal structure, mutations 
that increase the overall enzyme stability [121] [122] [123]. This led 
to a more robust HMFO variant which allowed a significantly more 
efficient conversion of HMF into FDCA [17]. The biocatalytic potential 
of HMFO is definitely not limited to the synthesis of FDCA. Faber and 
coworkers focused on improving HMFO through enzyme engineering 
towards production of other carboxylic acids from primary alcohols. By 
rational engineering they improved the binding of the gem-diol form of 
the aldehyde in the active site to boost aldehyde-oxidase activity. This 
was achieved by mutating two residues in the active site. The mutant 
W466H V465T merged high activity and high enantioselectivity, and 
allowed an improved ratio (37% against the 6% of the wild type) of 
carboxylic acid to aldehyde formation [124]. HMFO has also been used 
for the synthesis of enantiopure sec-thiols to answer the demand of 
chiral building blocks for pharmaceuticals [125]. Classical chemical 
based approaches to obtain nonracemic sec-thiols involve complex 
procedures that involve expensive catalysts [126]. It was shown that 
HMFO can be used for the kinetic resolution of 1-phenylethane-thiols 
via enantioselective oxidation [125].
METHANOL OXIDASE
Methylotrophic organisms such as Pichia pastoris have evolved to 
utilize lower primary alcohols as sole source of carbon. A crucial 
enzyme, present in different isoforms, involved in the metabolism of 
methanol is the FAD-containing methanol oxidase [127] [128]. Meth-
anol oxidase (EC 1.1.3.13) belongs to the GMC-like family and is also 
often referred to as alcohol oxidase (AOX). Expression of AOX in the 
original yeasts is strong and tightly regulated, absent during growth 
in presence of glucose or ethanol and strongly induced by methanol 
[129]. This pathway is so well-regulated that quite a number of studies 
have been carried out for biotechnological applications of the involved 
promotors such as in recombinant proteins expression in yeast [130] 
[131] [132]. AOX is localized in peroxisomes where the methanol is 
oxidized to formaldehyde and H2O2, the latter is then broken down into 
oxygen and water by peroxisomal catalase [133]. Methanol is the nat-
ural substrate, but in vitro experiments have revealed that AOXs can 
also oxidize short aliphatic alcohols such as ethanol and 1-propanol. 
whole-cell biocatalysts and single enzyme [115]. The discovery of HMFO 
(EC 1.1.3.47) from Methylovorus sp. strain MP688 in 2014 by the Fraaije 
group represented a major breakthrough in the quest for a catalyst 
capable to convert HMF into FDCA [116]. HMFO was the first oxidase 
shown to be able to convert HMF into FDCA via three oxidative steps. 
The ability to convert alcohols to the corresponding carboxylic acid is a 
known feature among the members of the GMC family [117] [118]. The 
catalytic mechanism starts with the oxidation of the alcohol group of 
HMF resulting in the formation of furan-2,5-dicarbaldehyde (DFF). The 
hydrated gem-diol form of the aldehyde moiety can be further oxidized 
yielding 5-formylfuran-2- carboxylic acid (FFCA) and the last oxidation 
yields to FDCA Scheme 3 [119].
Despite the outstanding ability of this oxidase to generate FDCA 
using HMF as starting material, the yield of FDCA was poor and the 
main product of the conversion was FFCA. Thanks to the elucidation 
of the crystal structure of HMFO it was possible to tailor the active site 
to improve the last rate-limiting oxidation step [120]. 
The elucidated crystal structure revealed that HMFO folds into a glob-
ular and compact structure organized in two domains: an FAD-binding 
domain with the classical Rossmann fold and a smaller cap domain 
that covers the flavin active site [120]. The enzyme active site can be 
described as a deep and narrow cleft. A conserved histidine (H467) of 
the GMC family is located at the bottom of the active site cleft close 
to the flavin ring. This residue was shown to be essential for catalysis 
[116]. HMFO is efficient in oxidizing various primary alcohols while it 
also displayed a low but significant activity on aldehydes. Oxidation 
of aldehydes was found to be catalyzed by oxidizing the hydrate form 
of the aldehydes, the gem-diols. Yet, gem-diols present bulkier substit-
uents on the α-carbon which led to the speculation that an enlarged 
active site cleft would improve the activity on aldehydes. This led to 
the preparation of a double mutant (W466F/V367R) which display a 
1000-fold improved catalytic efficiency (kcat/KM) for FFCA compared 
with the wild type HMFO. The mutation W466F increased the activ-
ity towards the aldehyde of FFCA by enlarging the active site cleft, 
 
Scheme 3 Oxidation reaction of 5-hydroxymethylfurfural (HMF) to 2,5-furandicar-
boxylic acid (FDCA) by HMFO. 
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mutant PcAOX, when tested for glycerol oxidation, proved to be F101S. 
Thanks to an enlarged cavity, this variant was able to convert glycerol 
to glyceraldehyde with a kcat value of 3 s−1 [142]. As previously men-
tioned only a few oxidases are able to perform a double oxidation of 
alcohols into the corresponding carboxylic acids (e.g. HMFO). It was 
found that the variant F101S of PcAOX was also able to catalyze double 
oxidations of alcohols. This led to the interesting finding that, when 
offered diols, this oxidase can produce hydroxy acids by selectively 
oxidizing only one hydroxyl group [89]. Among all the substrate tested, 
some of the corresponding lactones or hydroxy acids find application 
as building block for biodegradable polymers [143]. 
CONCLUSIONS
Flavin cofactors represent crucial molecules in nature. Remarkably, 
about 1-3% of the genes in prokaryotic and eukaryotic organisms are 
predicted to encode for FAD- and FMN-containing proteins [21]. Nature 
evolved a palette of different flavin-containing enzymes for the oxida-
tion of alcohols and amines. Flavoprotein oxidases in particular are 
particularly suited for such reactions and have been studied in detail 
to understand (1) what their role is in nature, (2) how they function at 
molecular level, and (3) whether they can be used for biotechnological 
applications. Genome mining has been efficient in the last 20 years 
bringing to light new remarkable oxidases such as HMF oxidase, eu-
genol oxidase [31], sulfhydryl oxidases [144] and chitooligosaccharide 
oxidase [145]. The last five years are experiencing an expansion of the 
toolbox for protein engineers: directed evolution and advanced molec-
ular biology techniques and computational tools are becoming every 
day cheaper, faster and/or more reliable. This will help in discovery 
and engineering of flavoprotein oxidases with pre-defined properties, 
suitable for industrial applications.
Another form of AOX has been found in basidiomycetes. In these fungi 
it is differently localized. In the wood-degrading fungi Gloeophyllum 
trabeum AOX has been found in the hyphal periplasmic space and in 
the extracellular matrix. The C-terminus indeed differs from the yeast 
AOX preventing translocation into peroxisomes. In basidiomycets AOX 
oxidizes the methanol that becomes available from the degradation 
of biomass. The generated H2O2 has been implicated to assist in the 
production of destructive radicals essential in lignin degradation 
[134] . Thanks to their ability of oxidizing various primary alcohols, 
AOXs have found applications in biosensors, mostly used for ethanol 
detection. System can employ amperometric electrodes to detect O2 
depletion or H2O2, production, or can be coupled bioenzymatic assays 
with horse radish peroxidase [135] [136]. Crystal structures of AOXs 
have elucidated only recently. It consists of an oligomeric assembly 
of eight identical subunits organized, each containing a strongly, but 
non-covalently, bound FAD [137]. The assembly pathway of AOX is 
quite complex. After synthesis of the monomeric apo enzyme, FAD 
binds with the help of cytosolic protein pyruvate carboxylase protein. 
Then, the FAD-containing AOX is transported to the lumen of the 
target peroxisome. Inside the organelle the assembly of the mature 
octamer takes place [129]. Recently, a newly discovered intracellu-
lar alcohol oxidase from the white-rot basidiomycete Phanerochaete 
chrysosporium (PcAOX) was reported to be active on glycerol [138]. 
Glycerol constitutes an abundant by-product of biodiesel manufacture. 
Over the last years there has been a growing interest in increasing 
the sustainability of this process through the valorization of glycerol 
[139] [140]. Therefore, the discovered glycerol oxidase may represent 
a valuable biocatalyst. Previous attempts to engineer an effective 
glycerol oxidase was not very successful: a variant of alditol oxidase 
showed  a kcat value for glycerol of only 0.06 s−1 [141]. The discovery of 
the PcAOX prompted further research. First, heterologous expression 
of PcAOX in Escherichia coli was established, which allowed more 
detailed biochemical studies [142]. It was soon found that PcAOX 
only showed very poor activity towards glycerol. Fortunately, the 
crystal structure could be elucidated which revealed a very similar 
structure when compared with the structure of yeast AOX [142]. It also 
provided an explanation for the observed preference for small alcohols 
as substrates (methanol and ethanol). The substrate binding site is 
rather small and solvent-inaccessible. With these structural insights, 
mutations were introduced with the aim to enlarge the substrate 
binding pocket, to allow binding of glycerol. In particular, residues 
F101 and M103 were targeted because they sterically limit the binding 
of substrates at the re-site of the flavin cofactor. The best performing 
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The solution to overcome the increasing demand for polymers, while 
fossil oil resources are rapidly depleting, could be the use of biomass 
as a renewable starting material [1]. A promising alternative to the pe-
troleum-based poly(ethylene-terephthalate) (PET) polymer is poly(eth-
ylene-furandicarboxylate) (PEF). Thanks to its similar characteristics, 
PEF has attracted attention because it is a bio-based polymer obtained 
from furan-2,5-dicarboxylic acid (FDCA) and this monomer can be syn-
thesized from the most abundant renewable material: carbohydrates 
[2,3]. For this reason, FDCA production has gained a lot of interest and 
different methods have been developed to convert carbohydrates or 
carbohydrate derived products (such as HMF) into FDCA [4]. Chemical 
methods to obtain FDCA from HMF by homogeneous or supported 
metal catalysts typically present several disadvantages: high costs, 
low yields, byproducts and the requirement of organic solvents which 
are not environmentally sustainable [5,6]. Several biocatalytic routes 
from HMF to FDCA have recently been described [7,8,9]. Among these 
approaches, only one was shown to be dependent on merely one biocat-
alyst, HMF oxidase (HMFO), a highly attractive feature. We identified 
HMFO in the predicted proteome of Methylovorus sp. strain MP688 
[8]. The oxidase contains a flavin adenine dinucleotide (FAD) cofactor 
as prosthetic group and only requires molecular oxygen as electron 
acceptor to catalyze various oxidation reactions which include alcohol 
and thiol oxidations [8,10]. HMFO was shown to be capable to convert 
HMF into FDCA in a three step reaction (Scheme 1) [8,10]. 
In order to develop HMFO into an industrially applicable biocatalyst, 
its catalytic and stability properties have to be improved. While the 
enzyme is efficient in catalyzing the first step in the catalytic cascade, it 
is rather inefficient in the last step. Furthermore, the enzyme displays 
only a modest stability. Upon elucidating the crystal structure of HMFO, 
we successfully identified mutations that improve its performance 
in oxidation of the hydrated form of 5-formyl-2-furancarboxylic acid 
(FFA) to FDCA, the last step in the catalytic cascade [11]. The mutant 
ABSTRACT
Background HMF oxidase (HMFO) from Methylovorus sp. is a re-
cently characterized flavoprotein oxidase. HMFO is a remarkable 
enzyme as it is able to oxidize 5-(hydroxymethyl)furfural (HMF) 
into 2,5- furandicarboxylic acid (FDCA): a catalytic cascade of three 
oxidation steps. Because HMF can be formed from fructose or other 
sugars and FDCA is a polymer building block, this enzyme has gained 
interest as an industrially relevant biocatalyst. 
Results To increase the robustness of HMFO, a requirement for bio-
technological applications, we decided to enhance its thermostability 
by using the recently developed FRESCO method: a computational 
approach to identify thermostabilizing mutations in a protein struc-
ture. To make this approach even more effective, we now developed a 
new and facile gene shuffling approach to rapidly combine stabilizing 
mutations in a one-pot reaction. This allowed the identification of 
the optimal combination of seven beneficial mutations. The created 
thermostable HMFO mutant was further studied as a biocatalyst for the 
production of FDCA from HMF and was shown to perform significantly 
better than the original HMFO.
Conclusions The described new gene shuffling approach quickly dis-
criminates stable and active multi-site variants. This makes it a very 
useful addition to FRESCO. The resulting thermostable HMFO variant 
tolerates the presence of cosolvents and also remained thermotolerant 
after introduction of additional mutations aimed at improving the 
catalytic activity. Due to its stability and catalytic efficiency, the final 
HMFO variant appears to be a promising candidate for industrial scale 
production of FDCA from HMF
Scheme 1 Oxidation reaction of 5-hydroxymethylfurfural (HMF) to 2,5-furandicar-
boxylic acid (FDCA) by HMFO
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RESULTS AND DISCUSSION
Computational Screening. The in silico phase of the FRESCO strategy 
was necessary to create an enriched library of single point mutants 
of HMFO. The crystal structure of the reduced form of the enzyme 
( PDB:4UDQ) was selected as model as it was solved at a better reso-
lution (1.6 Å) than the oxidized enzyme [11]. Using this structure all 
possible point mutations were modelled (excluding residues that are 
within 5 Å from the FAD cofactor) and their respective values in free 
energy of folding were compared with that of the wild type enzyme 
(∆∆GFold). By omitting the residues that are close to the active site, 
the risk of creating a mutant with lower or no activity is limited. The 
first in silico step consisted of a selection based on free energy predic-
tion: single mutants with a predicted ∆∆GFold higher than −5 kJ mol−1 
were discarded. This decreased the number of variants to screen 
from 9044 to 744. The Dynamic Disulfide Discovery (DDD) algorithm 
was not included in this FRESCO approach because disulfide bonds 
may complicate protein expression [20]. The MD simulations of the 
744 variants were visually inspected comparing the modelled structure 
of the wild-type with the mutants ones. The goal was to select variants 
with putative improvements in their thermostability profile. The 
screening was based on avoiding features that are normally found to 
cause a decrease in stability such as an increased flexibility (backbone 
and sidechain), an increase in hydrophobic surface exposure and 
diminished hydrogen-bonding interactions [21]. Those 140 mutants 
that scored well in the free energy of folding and did not show such 
aberrant structural features upon MD simulation and visual inspec-
tion, were selected to be experimentally tested for thermostability.
Screening of single mutants. Using PCR all 140 mutations were 
introduced in the HMFO-expression plasmid. The 140 mutant proteins 
and wild-type HMFO were produced in 96-well plates, which allowed 
efficient testing of all variants. To establish the effect of each mutation 
on stability the apparent melting temperature (Tmapp) was determined 
for each variant using the ThermoFAD assay [22]. The latter method 
reports on the temperature at which the flavin cofactor is released 
from the protein, thereby becoming more fluorescent because flavin 
fluorescence is typically quenched when it is bound in a protein. This 
provides a good estimate of the thermostability of the studied flavo-
protein as cofactor release is the result of protein unfolding. Because 
HMFO is well expressed, we did not only determine the Tmapp value for 
each variant after enzyme purification, but the Tmapp was also measured 
using cell extracts. This revealed that the stability of the variants could 
V367R-W466F HMFO was found to be the best variant for FDCA produc-
tion with a kcat/Km value for FFA conversion >1000-fold higher than 
for the wild-type enzyme [11]. Yet, as often observed when engineering 
enzyme activity, the higher catalytic performance was at the expense 
of enzyme thermostability.
Since HMFO has the potential to become an important biocatalytic 
tool, development of a robust variant is essential. An enzyme with 
a higher thermostability will be more suitable for use under harsh 
reaction conditions such as elevated temperatures and the presence of 
organic cosolvents [12]. Moreover a stable enzyme is the ideal template 
for further enzyme engineering efforts aimed to improve or change 
its catalytic properties [13]. Several methods have been designed to 
enhance the (thermo)stability of enzymes [14]. Completely random 
approaches like directed evolution can be effective but are time con-
suming and require high-throughput screening methods [15].
Rational design of stabilizing mutations is still challenging due to 
the fact that it is too complicated to accurately explain the effects of a 
mutation in terms of ΔΔH and ΔΔS [16]. Yet, state-of-the-art computa-
tional methods have evolved to such a level that they have predictive 
value in selecting putative thermostabilizing mutations. This can 
be used as input for the design of relatively small mutant libraries 
for screening in vitro [17]. We have recently developed a Framework 
for Rapid Enzyme Stabilization by Computational libraries (FRESCO) 
which is a computationally assisted method that includes predicting 
a large number of independent stabilizing mutations that are in silico 
screened in order to define a relatively small set of mutations that need 
to be tested experimentally  [18,19]. This approach has demonstrated 
its validity with different enzymes, leading to high Tmapp improvements 
of up to 32  °C [20,21,22]. The initial steps of the FRESCO strategy 
consist of computational and visual selections based on free energy 
predictions and molecular dynamic (MD) simulations of single point 
mutations. This is followed by an in vitro phase to identify variants 
with significantly improved stability and finally the combination 
of the selected mutations should result in a highly stable enzyme 
variant. FRESCO is an attractive approach when dealing with a protein 
for which the crystal structure has been determined and, therefore, 
HMFO is a suitable candidate. The aim of this work was to obtain a 
stable HMFO variant which performs well in the conversion of HMF 
into FDCA.
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to merge certain wanted properties of two or more distinct proteins 
into one[25,26]. We developed a controlled approach that can be ap-
plied in cases when it is desired to test all different combinations of 
several specific gene fragments (with predefined mutations). In our 
method we take advantage of the fact that gene (fragment) synthesis 
has become relatively cheap [27]. For the gene shuffling library, we 
chose the 8 mutations which resulted in the highest Tmapp values: I73V, 
H74Y, Q187E, G356H, V367L, T414K, A419Y, and A435E. To assess if 
the catalytic properties of the corresponding mutant enzymes were 
unaffected, we measured HMFO activity towards vanillyl alcohol [8]. 
The benefit of using this substrate is that it allows direct detection of 
product formation as the formed vanillin displays light absorbance 
at 340 nm. Gratifyingly, all mutants showed similar activity when 
compared with the wild-type enzyme (Additional file 2: Table S2). 
Before performing gene shuffling, the mutations I73V and H74Y, being 
neighboring residues, were combined to verify whether they display 
an additive effect. This was found to be the case as the double mutant 
presents a Tmapp that is 6 °C higher when compared with the wild-type 
enzyme (the single mutations displayed 3-4 °C higher Tmapp values, 
Figure 1). This double mutation was included in the gene shuffling 
approach instead of the two individual mutations, reducing the num-
ber of mutation sites to 7. The aim of the gene shuffling approach 
was to create a library of all the possible combinations (128) of the 
selected 7 sites and subsequently test them for thermostability and 
activity towards HMF. The gene shuffling protocol described in this 
work is based on the Golden Gate cloning system [25]. Previously, 
other approaches used type IIs restriction enzymes to combine gene 
fragments or plasmid modules; these methods involve cloning of 
each module flanked by BsaI sites in individual vectors, or add type 
IIs restriction enzyme sites by separate PCRs for each module [29,30]. 
The Golden Gate gene shuffling we developed for the FRESCO strategy 
is a one-pot reaction that involves only three designed vectors and a 
single restriction-ligation reaction (Figure 2). 
The first step was the design of two synthetic genes, one wild-type 
version and one with the selected 7 mutations, each containing 8 BsaI 
restriction sites that flank the 7 gene modules that contain the target 
mutation sites. The positions of the modules were defined identically 
for the two versions and were designed such that all the desired muta-
tion sites could be introduced in separate modules and that the 4 nucle-
otide overhangs for the ligation were unique and not palindromic. The 
innovation of this method is in the design of the BsaI restriction sites. 
Each module is flanked by two BsaI sites: between two modules there 
are two mirrored BsaI sites and the 4 overhang nucleotides at the end 
also be measured in cell extracts as the Tmapp values obtained with 
cell free extracts were quite consistent compared with the purified 
enzymes. It demonstrates that the ThermoFAD method can be a very 
powerful approach to efficiently screen a large set of flavoprotein 
variants without the need for enzyme purification. Importantly, the 
ThermoFAD measurements revealed 17 mutations that led to a sig-
nificant positive ΔTmapp in comparison with the wild-type enzyme 
(Figure 1) (Additional file 1: Table S1). 
Golden Gate Gene Shuffling. As next step in the FRESCO method, 
the best combination of beneficial mutations needs to be identified. 
The addition of several single mutations does not necessarily lead 
to a more thermostable variant, because beneficial single mutations 
may not be compatible. So far the strategy to combine the mutations 
was based on a good analysis of the ΔTmapp together with the muta-
tion position and its predicted effect. Yet, such an approach is time 
consuming since the mutations need to be combined in a step-wise 
fashion, one by one or in groups and tested at each step [18,20,21,22]. 
We set out to develop a more effective method to quickly identify 
the best combination of mutations that results in a stable and active 
variant. For this, we aimed at randomly combining mutations through 
a gene shuffling approach. Various gene shuffling methods have been 
developed in the field of protein engineering, often with the focus 
Figure 1. ΔTmapp values of 17 selected mutants. The values correspond to an increase 
in Tmapp when compared with WT HMFO (Tmapp = 48.5 °C)
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establish Tmapp of the variants and also their activity towards HMF. To 
be sure of screening all the possible combinations, the tested library 
size was 3.5 fold the number of possible combinations. The results 
of the ThermoFAD analysis showed that the 8xHMFO (I73V, H74Y, 
Q187E, G356H, V367L, T414K, A419Y, A435E) was the most thermo-
stable variant with an improvement of 13 °C compared with the WT 
(Tmapp = 48.5 °C). Yet, an alignment of the best 9 multi-site mutants that 
presented an higher Tmapp together with a preserved ability to oxidize 
HMF demonstrated that the mutation Q187E had a negative effect on 
the activity (Additional file 3: Table S3). This shows the advantage of 
using a gene shuffling approach to evaluate the best thermostable and 
active mutant. Therefore the best multiple mutant was considered 
to be the 7xHMFO mutant (I73V, H74Y, G356H, V367L, T414K, A419Y, 
A435E) with a Tmapp of 60.5 °C and kcat and Km values comparable with 
the wild-type enzyme (Table 1) [10]. 
To further investigate the thermostable properties of the 7xHMFO 
mutant, its stability over time at 40 °C was investigated. The 7xHMFO 
variant presented a remarkable stability compared to the wild-type 
enzyme. While wild-type HMFO completely lost its activity after 2 days, 
the thermostable variant retained 50% of its activity even after 10 days 
of incubation at 40 °C (Additional file 5: Figure S2). Since HMFO is able 
to oxidize many different substrates, including compounds that are 
poorly soluble in water, we investigated the stability in the presence 
of different cosolvents. The 7xHMFO showed a much higher tolerance 
towards four commonly used cosolvents when compared with the 
wild-type enzyme (Figure 3). The 7xHMFO mutant with its higher 
thermostability, solvent-tolerance, and preserved catalytic activity 
represents an excellent template for further engineering.
Engineering of thermostable HMFO variant for FDCA production. 
To further tune the 7xHMFO variant towards conversion of HMF into 
FDCA we introduced two mutations (V367R and W466F) in the active 
of each module are replicated at the beginning of the following module 
to allow a scarless ligation. By performing the one pot Golden Gate 
cloning reaction on the mixture of the two donor vectors, containing 
the two synthetic genes, and the acceptor pBAD vector, all possible 
combinations of the 7 gene fragments are created in the pBAD-based 
expression vector. The Golden Gate gene shuffling library was analyzed 
by sequencing to confirm the heterogeneity and accuracy of the shuf-
fling of gene fragments. The results showed that 97% of the colonies 
contained the correct restriction pattern and the shuffling efficiency 
was 65%. This indicates that per 100 clones, 65 contain non-redundant 
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Figure 2. Design of the synthetic genes for Golden Gate gene shuffling. (a) BsaI 
recognition sites between two modules are flanked and mirrored. The four nu-
cleotides at the end of one fragment are replicated at the beginning of the next 
one to avoid nucleotide loss after the ligation. (b) Donor vectors have the same 
fragment arrangement. The wild-type fragments are represented in green, while 
the fragments in orange have one mutation site each. The dotted sections (pUK57 
backbone and BsaI sites) are lost after the ligation. The shuffled library consists of 
pBAD SUMO-HMFO vectors with a random combination and correct order of the 
7 gene modules (with mutations)
Table 1. Steady-State Parameters of the different HMFO variants on HMF a
HMFO kcat (s-1) Km (mM) kcat/Km (s-1mM-1)
WT 13.7 1.52 9.03
7xHMFO 11.8 0.63 18.7
a Kinetic parameters were determined by measuring H2O2 formation in a coupled 
assay using HMF as substrate (Additional file 4: Figure S1).
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W466F HMFO mutant we tested the conversion rates using HMF as a 
substrate. The best thermostable variant for FDCA production turned 
out to be the newly engineered 8BxHMFO. The data revealed that this 
HMFO variant performs significantly better than the wild-type and the 
double mutant (Figure 4) (Additional file 6: Table S4). 
At 25 °C an almost full conversion in 24 hours could be achieved while 
the conversion with the double mutant and the wild type enzyme 
remained below 50% and 5%, respectively. Since all the generated 
thermostable HMFO variants exhibit Tmapp values higher than 50 °C 
we decided to perform conversions also at 40 °C. At this temperature, 
only the 8BxHMFO mutant performed well (> 95% conversion in only 
9 hours) (Additional file 7: Table S5). The kcat/Km of the 8BxHMFO is 
0.1 s-1mM-1 which compared to the reported kcat/Km value of the double 
mutant is relatively low (2.2 s-1mM-1) (Additional file 8: Figure S3) [11]. 
This indicates that the higher conversion is largely due to an improved 
operational stability. The results indicate that this engineered version 
of HMFO can be used for longer time and can lead in this way to higher 
amounts of FDCA.
site that have been shown to be beneficial for FDCA production from 
HMF [11]. Since V367 had already been mutated in the 7xHMFO variant 
(V367L) we included in the analysis also another 8xHMFO variant with 
only the W466F mutation. The variants were tested and as expected 
the additional mutation(s) introduced into the 7xHMFO decreased 
the Tmapp. Yet, the stability remained significantly higher than the 
wild-type enzyme (Table 2).
To determine whether the thermostable variants are more potent 
biocatalysts than the previously described wild-type and/or V367R 
Figure 3. Tmapp in the absence or presence of 15% 1,4-dioxane, methanol, dimethyl 
sulfoxide, or ethanol. Kpi is the control in 50 mM phosphate buffer, pH 8.0







a Tmapp values of HMFO variants (30 μM) obtained by ThermoFAD in phosphate buffer 
50 mM pH 8.0. b The 7xHMFO variant includes the mutations: I73V, H74Y, G356H, 
V367L, T414K, A419Y, A435E. c The 8AxHMFO variant includes the mutations: I73V, 
H74Y, G356H, V367L, T414K, A419Y, A435E and W466F, d The 8BxHMFO variant 
includes the mutations: I73V, H74Y, G356H, V367R, T414K, A419Y, A435E and W466F.
Figure 4. Production of FDCA from HMF at 25 °C by HMFO variants. WT (filled 
triangle), V367R W466F HMFO (filled circle), 8BxHMFO (I73V-H74Y, G356H, V367R, 
T414K, A419Y, A435E, and W466F) (filled square). Conversions were performed in 
duplicates in phosphate buffer 50 mM pH 8.0, HMFO 2.0 μM, HMF 5.0 mM, 25 °C
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Genetic Engineering. For all the experiments the His6x-SUMO-
HMFO fusion has been used as it has been demonstrated before that 
the SUMO protein fused at the N-terminus does not affect the activity 
nor the thermostability of HMFO [10].The gene single point variants, 
the double mutant I73V H74Y, the 8AxHMFO and the 8BxHMFO 
were obtained from pET SUMO-HMFO or pBAD SUMO-7xHMFO by 
whole-plasmid PCR with PfuUltra II Hotstart PCR Master Mix (Agi-
lent). Template DNA was cleaved with DpnI (New England Biolabs) 
for at least 2 hours at 37 °C. Escherichia coli NEB 10β (New England 
Biolabs) chemically competent cells were transformed (heat shock 
at 41 °C for 45 seconds) and cells plated on 50 μg·mL-1 kanamycin or 
100 μg·mL-1 ampicillin LB agar plates. All mutations were confirmed 
by sequencing. 
Golden Gate Gene Shuffling. The 8-fold mutants were obtained us-
ing a gene shuffling approach. For this, we designed two synthetic gene 
versions of hmfo: one with 7 modules each containing one mutated 
region (the first module containing 2 mutations, and the 8 mutations 
are: I73V-H74Y, Q187E, G356H, V367L, T414K, A419Y, A435E) and the 
other synthetic gene with the same modules arrangement but with-
out mutations, corresponding to the wild type DNA sequence. Each 
module had been designed to be flanked by BsaI recognition sites: 
NGAGACC at the beginning and GGTCTCN at the end. Moreover at the 
beginning of each fragment the last 4 base pairs (bp) of the previous 
module are repeated (or the 5’- 4 bp of the overhang region of the 
acceptor plasmid in the case of the first fragment and at the end of the 
7th fragment are replicated 4 bp of the 3’- ligation site of the receiving 
plasmid). The BsaI cutting sites have been chosen in order to be unique 
(at least 3 out of 4 nucleotides in the sticky end have to be different) and 
not palindromic to avoid unwanted ligations (Additional file 9: Gene 
Sequences). The synthetic genes have been ordered (GenScript) cloned 
in two pUK57. A derivative of pBAD SUMO vector designed with BsaI 
cutting site 5’-TGGTngagacc and ggtctcnCTTG-3’) was used as receiving 
vector. The restriction-ligation reaction was set up in 20 μL volume 
with the components: pBAD SUMO 3.75 ng·μL-1, pUC57wt 2.5 ng·μL-1, 
pUC578xmutant 2.5 ng·μL-1, T4 DNA ligase buffer (Promega), T4 DNA 
ligase 1.5 U·μL-1 (Promega), BsaI 1 U·μL-1 (New England Biolabs); the 
thermocyler program was: incubation at 37 °C for 5 minutes and at 16 °C 
for 10 minutes repeated 50 times, followed by a final incubation at 50 °C 
for 10 minutes (final digestion) and at 80 °C for 10 minutes (enzyme 
inactivation). The restriction-ligation reaction (5 μL) were used to 
transform 100 μL of chemically competent NEB 10β cells plated on 
100 μg·mL-1ampicillin LB agar plates. The hmfo variants were verified 
CONCLUSIONS
In this work we further developed the FRESCO protocol by developing a 
novel and efficient approach for combining individual stabilizing mu-
tations. The Golden Gate gene shuffling described in this study was fun-
damental to rapidly identify the best combination of thermostabilizing 
mutations that led to a stable and active HMFO variant. The engineered 
7xHMFO variant presented a Tmapp improvement of 12 °C compared with 
the wild-type enzyme together with an improved cosolvent tolerance. 
We could also demonstrate that this thermostable variant of HMFO can 
be used as template to introduce a destabilizing mutation in the active 
site. One of the resulting HMFO mutants displayed superior perfor-
mance compared to previously reported HMFO variants in converting 
HMF in a three-step one-enzyme reaction into FDCA.
MATERIALS AND METHODS
All materials were acquired from Sigma-Aldrich unless otherwise 
specified.
Computational Methods. The FRESCO method was employed to 
obtain a thermostabilized variant of HMFO. Computational modeling 
was performed using the 4UDQ X-ray structure of HMFO (1.6 Å res-
olution). To avoid mutations that could interfere with the active site, 
only residues that were > 5 Å away from FAD were mutated [11]. The 
computational selection was started with calculating the predicted 
change of free folding energy (ΔΔGFold) with FoldX (foldx.crg.es) and 
Rosetta-ddg (www.rosettacommons.org) [18,19-]. For Rosetta, the 
so-called row-3 protocol (described by Kellogg et al. in row 3 of their 
table 1) was invoked by using the following options: -ddg::weight_
file soft_rep_design -ddg::iterations 50 -ddg::local_opt_only true 
-ddg::min_cst false -ddg::mean true -ddg::min false -ddg::sc_min_only 
false -ddg::ramp_repulsive false -ddg::opt_radius 8.0 [29]. For FoldX, 
the used options were --command=BuildModel --numberOfRuns=5. 
The single point mutations with a predicted ΔΔGFold< -5 kJ mol-1 were 
subsequently submitted to MD simulations under Yasara as previously 
described [18,19]. The averaged structures from the MD trajectories 
were visually inspected comparing the variant simulations with the 
wild type HMFO while examining backbone and side-chain flexibility, 
hydrogen bonds and hydrophobic exposure. This last in silico step is 
to further reduce the number of potentially thermostable variants to 
experimentally screen. 
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was removed and the column was washed 2 times with 200 μL of 
50 mM Tris HCl pH 8.0 with 150 mM NaCl, and one time with the same 
buffer containing 5 mM imidazole. The protein was eluted with 100 μL 
of 50 mm Tris HCl with 150 mM NaCl containing 500 mM imidazole. 
The eluate was desalted in 50 mM phosphate buffer pH 8.0 using PD 
MultiTrap G-25 plates (GE-Healthcare). 
Thermostability assay. The melting temperature of HMFO cell free 
extract or purified variants was tested by the ThermoFAD method, 
which allows to determine the unfolding temperature based on the 
release of the flavin cofactor [8,24]. This assay was performed using 
20 μL of CFE or 20 μL of purified enzyme in 50 mM phosphate buffer at 
pH 8.0. The ThermoFAD was also used to determine enzyme concen-
tration after the small-scale purification based on the dT/fluorescence 
value using a calibration line. The calibration curve prepared with 
several WT concentrations proved that enzyme concentration does 
not affect the Tmapp.
Activity assays. All the activity assays were performed in 50 mM 
phosphate buffer pH 8.0 at 25  °C. The HMFO mutants I73V, H74Y, 
Q187E, G356H, V367L, T414K, A419Y, A435E were tested using enzyme 
activity towards vanillyl alcohol as reported previously [8]. The gene 
shuffling library was tested with the coupled H2O2 detection assay: 
horseradish peroxidase (HRP) (Sigma), 0.004 U·μL-1, 4-aminoanti-
pyrine (0.1 mM), 3,5- dichloro-2-hydroxybenzenesulfonic acid (1 mM) 
and HMF (10 mM), measuring at 515 nm (ε515=26 mM-1cm-1) the forma-
tion of pink product due to H2O2 production during the oxidation of 
HMF by HMFO. This HRP coupled assay was also used to determine 
kcat, Km, and the activity after the incubation at 40 °C for HMFO wild 
type and for the thermostable.
Product identification. The conversion performed by HMFO WT, 
HMFO V367R-W466F, HMFO I73V-H74Y-G356H-V367L-T414K-A419Y-
A435E (7xHMFO), HMFO I73V-H74Y-G356H-V367L-T414K-A419Y-
A435E-W466F (8AxHMFO), HMFO I73V-H74Y-G356H-V367R-T414K-
A419Y-A435E-W466F (8BxHMFO), using 5.0 mM 5-(hydroxymethyl)
furfural as a substrate were carried out at 25 °C or 40 °C, with shaking 
at 1000 rpm. After the conversion, the enzyme was inactivated at 80 °C 
for 10 minutes and eliminated by centrifugation. The products were 
analyzed by high-performance liquid chromatography as described 
previously [8].
first by colony PCR (DreamTaq Green PCR Master Mix, ThermoFisher) 
to determine the inserts size and then by sequencing. 
Large scale expression and purification. For HMFO expression, a 
culture was started by inoculating 5 mL of preculture (LB supplemented 
with 50 μg·ml-1 kanamycin or 100 μg·ml-1 ampicillin) in 100 mL TB 
(Terrific Broth with the same antibiotic). In the case of pET constructs, 
protein expression was induced at OD600 0.5 with 1.0 mM isopropyl 
β-d-1-thiogalactopyranoside (IPTG), and with 0.02% L-arabinose in 
the case of the pBAD SUMO-HMFO construct. The latter was obtained 
by cloning the HMFO DNA sequence using NdeI and HindIII (NEB) in 
pBAD SUMO. Cells were grown overnight at 24 °C 135 rpm and har-
vested at 5000 g for 10 min at 4 °C. The cells pellet was resuspended 
in 10 mL of 50 mM Tris HCl pH 8.0 with 150 mM NaCl and sonicated 
3’’ on 6’’ off at 70% amplitude. The enzyme was purified from the cell 
free extract as described previously [8]. 
Small scale expression. The single point variants were expressed 
in E. coli BL21(DE3) cells with the pET SUMO-HMFO vector. The cul-
tures were prepared using 600 μL of overnight culture (LB supple-
mented with 50 μg·ml-1 kanamycin) to inoculate 5 mL TB containing 
50 μg·ml-1 kanamycin in a 24 well-plate. The multi-site variants were 
expressed with the pBAD SUMO-HMFO vector in E. coli NEB 10β cells; 
the cultures were made by inoculating 200 μL of overnight culture 
(LB supplemented with 100 μg·ml-1 ampicillin) in 800 μL of TB (100 
μg·ml-1 ampicillin) in 96 well-plate. The cultures were incubated at 
37 °C with a shaking at 300 rpm and induced with 1.0 mM IPTG (in 
case of E. coli BL21(DE3) cells carrying the pET SUMO-HMFO vector) 
or with 0.02% L-arabinose (E. coli NEB 10β cells carrying the pBAD 
SUMO-HMFO vector) at an optical density at 600 nm (OD600) of 2.0. 
Expression continued overnight at 24 °C with shaking at 550 rpm.
Small scale purification. Cells were harvested by centrifugation 
at 2250 g for 20 minutes at 4 °C. The cell-free extract was obtained 
after cell lysation: the cell pellet was solubilized in 200 μL lysis buffer 
(lysozyme 1 mg·ml-1, deoxyribonuclease I 0.5 mg·ml-1, MgCl2 10 mM 
in 50 mM Tris HCl pH 8.0). The solubilized pellet was incubated for 
30 minutes at 25 °C (shaking at 550 rpm) and then it was frozen in 
liquid nitrogen and centrifuged at 2250 g for 45 minutes at 4 °C. The 
soluble fraction was filtered (Whatman UNIFILTER 96-well Microplate, 
GE-Healthcare) at 7 g for 15 seconds at 4 °C and mixed with 100 μL of 
pre-equilibrated Ni-Sepharose resin (GE-Healthcare) for 15 minutes 
using an AcroPrep Advance 1 mL 96-well plate (Pall). The flow through 
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Additional file 3: Table S3. Multiple mutant alignment of the 9 best performing 




Q187E G356H V367L T414K A419Y A435E Tmapp
(°C)
kobs(s-1)
wt wt 59 <10
wt 60 <10
wt wt wt 59.5 <10
wt wt 59.5 <10
wt wt wt wt 57 <10
wt wt wt wt 59.5 <10
wt wt wt wt 59 <10
wt wt wt wt wt 59 <10
wt wt wt 58 <10
Additional file 4: Figure S1. Michaelis–Menten graph of WT and 7xHMFO. Kinetic 
assay performed with HRP peroxidase in 50 mM phosphate buffer pH 8.0 at 25 °C 
using HMF as substrate.
Best-fit values wt 7xHMFO
kcat (s-1) 13.72 11.79
Km (mM-1) 1.518 0.6319
Std. Error
kcat (s-1) 0.70 0.64
Km (mM-1) 0.24 0.14
95% Confidence Intervals
kcat 12.10 to 15.34 10.30 to 13.28
Km 0.96 to 2.08 0.30 to 0.96
R2 0.98 0.96
SUPPORTING INFORMATION
Additional file 1: Table S1. ΔTappm of the best 17 single mutants. Results of the 
ThermoFAD assay performed on cell-free extract and purified enzyme.


















Additional file 2: Table S2. Activity towards vanillyl alcohol of HMFO mutants 
I73V, H74Y, Q187E, G356H, V367L, T414K, A419Y, and A435E. All the activity assays 
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Additional file 7: Table S5. Percentages of products formed during the oxidation of 
5 mM HMF by 2 μM of enzyme in phosphate buffer 50 mM pH 8.0 at 40 °C in Eppen-
dorf ThermoMixer C while shaking at 1000 rpm. Average values of two experiments 
(standard deviations were < 7%, with an average standard deviation of 1.0%). Samples 
with only phosphate buffer, substrate, and WT enzyme where used as control.
Time (h) Substrate/Product (%) WT V367R W466F 8BxHMFO
3 HMF 69.2 97.6 22.5
3 FFA 21.8 0.4 9.2
3 FDCA 0.8 0.1 68.1
6 HMF 64.5 98.7 9.6
6 FFA 27.9 0.4 4.6
6 FDCA 0.0 0.1 76.0
9 HMF 62.3 96.8 7.6
9 FFA 29.2 0.2 3.9
9 FDCA 0.4 0.1 110.4
12 HMF 60.3 96.1 1.8
12 FFA 28.8 0.4 0.0
12 FDCA 0.3 0.2 101.6
Additional file 8: Figure S3. Michaelis–Menten graph of 8BxHMFO. Kinetic assay 
performed with HRP peroxidase in 50 mM phosphate buffer pH 8.0 at 25 °C using 
FFA as substrate.
Additional file 5: Figure S2. Oxidation rates of HMF by HMFO wild-type and 
thermostable 7xHMFO variant after incubation at 40 °C [1 mM] in phosphate buffer 
50 mM pH 8.0. The activity test was performed with HRP peroxidase assay using 
HMF as substrate.
Additional file 6: Table S4. Percentages of products formed during the oxida-
tion of 5 mM HMF by 2 μM of enzyme in phosphate buffer 50 mM pH 8.0 at 25 °C 
in Eppendorf ThermoMixer C while shaking at 1000 rpm. Average values of two 
experiments (standard deviations were < 27%, with an average standard deviation 







6 HMF 0.0 54.2 18.7
6 FFA 79.6 3.4 2.7
6 FDCA 0.7 29.3 38.4
12 HMF 0.0 20.0 20.0
12 FFA 92.0 3.9 3.4
12 FDCA 3.0 37.0 73.0
18 HMF 0.0 40.3 11.4
18 FFA 100.9 3.2 1.8
18 FDCA 2.3 45.2 82.6
24 HMF 0.0 35.5 5.8
24 FFA 98.4 3.1 0.0
24 FDCA 3.1 47.9 94.1
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Gene name: HMFO-Mut, Length: 1738 bp, Vector name: pUC57-Kan, Cloning site: 
EcoRI/HindIII, 
BsaI recognition sites 


































Additional file 9: Gene Sequences. Synthetic gene sequences for WT and 8xHMFO 
for the Golden Gate gene shuffling.
Gene name: HMFO-Wt, Length: 1738 bp, Vector name: pUC57-Kan, Cloning site: 
EcoRI/HindIII, 
BsaI recognition sites 
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Every day the demand for sustainable plastic is becoming more press-
ing. In the scenario of replacing petrol-based polymers and materials, 
a furan building block is making its way to the market. 2,5-furandi-
carboxylic acid (FDCA) can be regarded as a renewable building block 
because it can be obtained through conversion of biomass-based car-
bohydrates. The first step in this process, a dehydration step, leads to 
the 5-hydroxymethylfurfural (HMF) [1]. FDCA can be produced from 
HMF through oxidation of this furan. For the latter process, various 
biocatalytic approaches have been investigated. The biocatalytic syn-
thesis of FDCA can be achieved by using a single enzyme or using a 
cascade with multiple enzymes, using immobilized enzyme(s) or fer-
mentative approaches [2,3]. Most of these biocatalytic studies focused 
on the identification of single biocatalysts or biocatalytic cascades, 
and only limited work has been reported on exploring industrial scale 
application of HMF-converting biocatalysts. The only enzyme known 
to be efficient in converting HMF to FDCA as single biocatalyst, is 
HMFO (EC 1.1.3.47) from Methylovorus sp. strain MP688. It represents 
a promising biocatalyst for FDCA production as extensively described 
in the introduction of this thesis and elsewhere in the literature [4,5]. 
Engineering of HMFO has been carried out in previous studies which 
resulted in the 8BxHMFO mutant. This variant was found to be more 
thermostable and displayed improved activity in converting HMF to 
FDCA when compared to than wild type HMFO. It has been demon-
strated that this engineered HMFO can be used to synthetize FDCA in 
a biocatalytic, environmentally and industrially sustainable way [6]. 
For future industrial application, the costs of the biocatalysts should 
be minimized. This can be achieved by creating a robust variant but 
also an efficient production system will contribute to a cost-effective 
production. In this chapter, two approaches for expressing HMFO have 
been studied: (1) spore-based enzyme production and immobilization 
using Bacillus subtilis, and (2) HMFO secretion by the yeast Komaga-
taella phaffii (also known as Pichia pastoris). 
Bacillus subtilis is an organism that has been used already for decades 
as a production host [7,8]. Moreover, recently B. subtilis has been de-
veloped for the purpose of protein spore display [9–12]. Compared 
to other microbial cell-surface display systems such as those with 
phage, E. coli or yeast, B. subtilis spore display is safer, and the displayed 
enzymes are often more stable than their native counterparts [13] 
[14]. The folding of the proteins that will be displayed on the spores 
occurs inside the mother cells before sporulation. As a result, there is 
no need to transport the target protein across the membrane [15]. An 
additional advantage of using the B. subtilis spore display system is the 
ABSTRACT
Two new strategies were pursued for heterologous production of 
5- hydroxymethylfurfural oxidase (HMFO). The first method employed 
was spore surface display of HMFO by using B. subtilis. It was expected 
that this system allows easy application of the biocatalyst for the 
conversion of HMF. In addition, it was conceivable that surface display 
beneficially impacts the stability of HMFO.
Several surface display gene constructs were generated employing 
CRISPR-Cas9 and various sporulation conditions were evaluated. Un-
fortunately, none of the constructs lead to surface display of active 
HMFO. The second approach for heterologous expression involved 
the use of the yeast P. pastoris for intracellular and secreted expression 
of HMFO. Though functional expression was achieved in yeast, both 
intra- and extracellularly, the yield of active HMFO was not compet-
itive when compared to the previously established Escherichia coli 
expression system.
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pJOE8999 and selection were performed as previously described [20]. 
Homologous integration of the construct encoding coat proteins fused 
to HMFO was confirmed by colony PCR of the 5’ and 3’ regions using 
primers annealing to the chromosomal and HMFO regions.
Construction of the plasmid pJOE8999. The plasmid pJOE8999 
was kindly donated by Prof. Dr. O.P. Kuipers [20]. The spacers (target 
sequence of sgRNA) were designed in order to target a small non-trans-
lated region at the 3’ terminus of the coat protein coding sequence 
that will be substituted by the HMFO sequence after the homologous 
recombination.
First the spacers were generated using single stranded oligonucle-
otides. The reaction mixtures were composed as follows: 20 μL of 
oligonucleotide forward [100 μM], 20 μL of oligonucleotide reverse 
[100 μM], 10 μL 5x T4 ligase buffer (Promega). The reaction mixtures 
were incubated in a thermocycler with the following program: 100 °C 
for 5 min and cooling down to 25 °C by a gradual decrease of 1 °C every 
30 s. The spacer was cloned with Golden Gate cloning system into the 
pJOE8999 using BsaI restriction sites, and confirmed by sequencing.
The homology recombination cassette was cloned into the pJOE8999 
carrying the spacer using NEBuilder® HiFi DNA Assembly or Gibson 
cloning method. First, it was necessary to amplify all the fragments. 
The B. subtilis genome was extracted and the regions 5’ and 3’ were 
amplified by PCR using primers overlapping with the vector in the SrfI 
cutting site and the HMFO. The 8BxHMFO coding sequence was ampli-
fied by PCR from a pBAD SUMO 8BxHMFO vector [21]. The NEBuilder® 
HiFi DNA Assembly reaction was used for the CotC,B,X,Z-HMFO fu-
sions, and the Gibson assembly for CotG-HMFO constructs (no relevant 
reason behind this choice, as both cloning methods are similar; Gibson 
assembly requires more time, longer overlapping regions but is less 
expensive). The pJOE8999 was cut with SrfI or, amplified and digested 
with DpnI (Gibson assembly in case of CotG). The amplified 5’ and 3’ 
regions were digested with SrfI and DpnI (to eliminate the methyl-
ated template), while the HMFO gene was digested only with DpnI. 
The NEBuilder® HiFi DNA Assembly reaction and Gibson assembly 
were performed according to instructions by the manufacturer. The 
obtained construct was checked by sequencing.
Sporulation and endospore isolation. Sporulation was performed 
in adapted Shaeffer medium (Difco Nutrient Broth 8 g/L, MgSO4 1 
mM, KCl 13 mM, MnSO4*4H2O 0.13 mM, CaCl2*2H2O 1 mM pH 7.0) 
at 37 °C or 30 °C at 135 rpm in an orbital shaker for 24-48 h until 
95% of the population consisted of spores. Spores and sporangial 
presence of molecular chaperones that facilitate the correct folding 
of the heterologous protein in the bacterial cytoplasm [16]. Another 
interesting aspect of spore display is that it leads to immobilization of 
the target protein on the spores. Immobilization of biocatalysts often 
results in a superior stability while spores will also allow easy recycling 
of the biocatalyst. Hence, expression of HMFO on spores would be an 
elegant approach to produce and immobilize the biocatalyst in one go.
As alternative approach for efficient production of HMFO, we also 
explored another known expression host: yeast. P. pastoris was chosen 
for establishing a system for high level of secretion of HMFO. Secretion 
of HMFO would allow facile production and usage of the biocatalyst as 
it would eliminate the need for costly procedures to isolate the biocat-
alyst. P. pastoris is known to support high expression levels of secreted 
protein. Production levels of more than 10 g/L are advertised on com-
mercial websites (Validogen®) [17]. P. pastoris is a methylotrophic yeast 
that gained a lot of commercial interest in the last decade as one of the 
most important organisms to produce heterologous protein owing to 
an efficient protein secretion machinery and for its ability to perform 
post-translational modifications. Various tools for protein production 
have been developed, such as expression vectors and induction proto-
cols [18]. A common strategy for heterologous protein expression in 
P. pastoris is by stable genome integration of the expression cassette 
and induction of expression by using methanol-regulated promoters 
of the methanol utilization pathway.
In this chapter, the results obtained for the expression of HMFO either 
on spores or secreted by yeast are presented. Although the results with 
expression in B. subtilis were disappointing, expression by P. pastoris 
was shown to be successful. Yet, the observed expression is still inferior 
when compared to the established intracellular expression in E. coli. 
More genetic engineering would be required to boost the expression 
in alternative recombinant expression hosts.
MATERIALS AND METHODS FOR EXPRESSION IN 
B. SUBTILIS
Bacterial strains, transformation and selection. E. coli NEB 10β 
cells were used for construction and amplification of the pJOE8999 
vector. E. coli chemically competent cells were transformed by heat 
shock and selection was done using kanamycin at 50 μg ml-1. The B. 
subtilis strain DB104 (nprE18 nprR2 AaprA3) double protease deficient 
strain was a kind gift from Prof. Dr. O.P. Kuipers [19]. The genomic DNA 
of this strain was used to amplify the regions necessary to construct 
the homologous recombination cassette, and it was used for transfor-
mation and sporulation experiments. B. subtilis transformation with 
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320 g peptone and 10 g yeast extract in 700 mL dH2O, autoclaved and 
added 200 mL 1.0 M phosphate pH 7.0 (autoclaved)), (2) BYPD (BYP 
with 100 mL dextrose 10x), (3) BYPM2 (10 mL methanol and 90 ml of 
water, BYP), or (4) BYPM10 (5 mL methanol and 95 mL of water, BYP). 
Conversion of HMF. Conversions were set up as follows: 50 mM KPi 
pH 8.0, 48 h, 25 °C, 5 mM HMF, 300 rpm, 500 µL in 4 mL glass vial.
Sample preparation:
• Extracellular: 250 uL of cell-free supernatant from cells expressing 
HMFO (OD600 = 44.00)
• Extracellular Control: 250 µL of cell-free supernatant from P. pas-
toris wild type cells
• HMFO: 0.23 nM of purified HMFO in 50 mM pH 8.0
• HMFO+media: 0.23 nM of purified HMFO with 250 µL cell-free 
supernatant from P. pastoris wild type cells
RESULTS
B. SUBTILIS SPORE DISPLAY
PLASMID CONSTRUCTION AND GENE KNOCK-IN
Plasmids for B. subtilis transformations were obtained after two 
cloning steps. First the target sequence was introduced to obtain a 
complete sgRNA. Then the three PCR products corresponding to the 
5’ region, 3’ region, and HMFO were ligated into the pJOE8999 to yield 
a complete vector for gene editing of the B. subtilis genome (Figure 1). 
cells of B. subtilis were collected by centrifugation, resuspended and 
washed once in phosphate buffer 70 mM pH 7.0. The suspension was 
treated next with a 0.5% lysozyme solution with or without 1mM 
phenylmethylsulfonyl fluoride (PMSF) for 1 h at 37 °C. The suspension 
was centrifuged next 12 min at 3200xg after which the pellet was 
washed as follows: once with 1 M NaCl, once with 1 M KCl, and one 
time with phosphate buffer 50 mM pH 8.0. Subsequently, samples 
were centrifuged 4 min at 10.000 g and the purified spores obtained 
were resuspended in phosphate buffer and stored at 4 °C [22]. The 
spores were checked microscopically following the Schaeffer-Fulton 
method for staining endospores. 
Product analysis. Conversions using the spores were performed in 
500 µL of total reaction volume using 5 mM HMF as substrate and 
various amounts of spores in the presence or absence of 10 µM FAD 
at 25 °C at 400 rpm for 24 h in an Eppendorf ThermoMixer. Reactions 
were inactivated by heating the samples at 95 °C for 10 min and cen-
trifuged. Products were analyzed as previously described [4].
MATERIAL AND METHODS FOR EXPRESSION IN 
P. PASTORIS
Vector assembly and yeast transformation. The 8BxHMFO-encod-
ing gene was obtained as yeast codon-optimized double stranded DNA 
fragment from Integrated DNA Technologies (IDT) to enable intracel-
lular expression, the DNA fragment was introduced into pBSY3Z by 
Gibson assembly employing SapI restriction sites, thereby yielding 
pBSY3Z-HMFO. Alternatively, it was amplified by PCR to add match-
ing ends and then cut (MlyI) and cloned in the pBSYDCsec by Gibson 
assembly. The result was pBSYDCsec_blunt1-HMFO for extracellular 
secretion. All constructs were used to transform E. coli XL-1 blue and 
colonies from single transformants were grown in liquid medium and 
used next for plasmid DNA extraction. This was used to confirm the 
proper sequence by DNA sequencing. To obtain linearized plasmid 
DNA, pBSYDCsec_blunt1-HMFO was digested with SwaI, whereas 
pBSY3Z- HMFO was treated with SwaI, BamHI or a combination of both. 
The linearized vectors were purified and used to transform competent 
P. pastoris and then plated on YPD zeocin 25 μg/mL [23]. 
Protein expression. Expression was performed first on a small scale in 
96 deep well plates to evaluate the best cassette integration site. To this 
end, the following media were used: (1) BYP (Buffered Yeast-Peptone: 




(96 deep well plate)
Large scale
(1L baffled flask)
0 - Starting cell culture 
in 180 μL BYPD
Starting cell culture (2 mL/5 ml 
overnight culture) in 180 mL BYPD
~48 1st induction 250 μL BYPM2 20mL BMM10
~56 2nd induction 50 μL BYPM10 1 mL methanol
~72 3rd induction 50 μL BYPM10 2 mL methanol
~80 4th induction 50 μL BYPM10 2 mL methanol
~96 - Harvest Harvest
Protein expression was verified by SDS-PAGE analysis, while oxidase activity was 
assessed by HRP coupled oxidase assay using HMF as substrate [4].
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The transformation of B. subtilis was successful, and the homologous 
integration was confirmed by PCR colony screening using primers an-
nealing on the chromosome (in a region external to the homologous 
cassette) and on the HMFO sequence as illustrated in Figure 2. Two PCRs 
were performed to amplify 800 bp fragments of the 5’ and 3’ regions.
SPORULATION AND ENDOSPORE ISOLATION
Spores of the generated recombinant B. subtilis strains could be ob-
tained as described above. Sporulation and endospore isolation were 
monitored microscopically. Micrographs confirmed sporulation and 
elimination of vegetative cells (Figure 3). Addition of PMSF or salt did 
not change the outcome. In every case sporulation and endospore 
The homologous recombination cassette contained the 5’ and 3’ 
regions from the B. subtilis genome (coat protein specific) and the 
HMFO-encoding sequence. Seven plasmids for expression of seven 
different HMFO-coat protein fusions were built (Table 2). For fusion, 
five different Cot proteins were targeted: CotB, CotC, CotG, CotX, and 
CotZ. For fusion to CotG, three different linkers were tested.
Figure 1. Map of complete pJOE8999. The pUC18 minimal origin, kanamycin resis-
tance gene (kanR), cas9 under the control of the B. subtilis specific mannose-inducible 
Pman promoter, and sgRNA (with a spacer coat protein specific) transcribed from 
the semisynthetic promoter PvanP*.
Table 2. Coat proteins with the respective linker for Cot-HMFO fusions.








Figure 2. B. subtilis genome before and after homologous recombination. The top part 
of the figure shows the B. subtilis genome before the transformation with pJOE8999. 
The bottom part depicts the bacterial genome after the gene editing procedure. The 
arrows represent the primers used for the colony PCR of the 5’ and 3’ regions.
Figure 3. Microscope pictures of cells stained by the Schaeffer–Fulton method. The 
primary stain is malachite green, which dyes the endospores. The counterstain is 
safranin, which dyes the bacterial bodies. The left micrograph shows spores before 
the lysozyme treatment, and the right micrograph shows spores after the treatment.
10 µm
B. subtilis genome
5’ region 3’ regionHMFOLinker
Homologous recombina�on casse�e
B. subtilis genome




76 CHAPTER 3: Development of Alternative Recombinant Expression Systems Results 77
3
represents HMFO (see for details the Supporting Information). Anal-
ysis of the HMFO sequence for possible glycosylation sites with the 
web server NetNGlyc 1.0 suggests two possible glycosylation sites: 
isolation gave positive results concerning the integrity of the spore 
and the elimination of vegetative cells (Figure 3).
HMF CONVERSIONS
Conversion of HMF using isolated spores showed no apparent HMFO 
activity. There was some minor conversion (~1%) observed, most likely 
due to some unknown nonspecific oxidase or dehydrogenase pres-
ent in the spores. In fact, a low conversion rate was found also in the 
negative control, using non-recombinant B. subtilis spores. There was 
no difference between cells carrying the different Cot-HMFO fusion 
constructs or non-recombinant cells: all could convert low amounts of 
HMF to FFA but no formation of FDCA was detected. To check whether 
HMFO was expressed as apo protein on the spores, the effect of adding 
FAD was tested. Nevertheless, the addition of 5 µM FAD did not lead 
to any improvement. These results suggest that no (functional) HMFO 
was displayed on the spores.
P. PASTORIS HMFO EXPRESSION AND HMF CONVERSION. 
Next, the use of yeast for intracellular and extracellular HMFO ex-
pression was explored. In the case of intracellular expression, the 
activity assay was performed after cell lysis. Unfortunately, no activity 
could be detected, possibly due to poor expression levels in the 96 well 
plate format and/or an inhibitory effect from the lysis buffer in the 
HRP coupled assay. Subsequently, the colony with the best random 
integration site leading to the highest level of expression was identified 
by SDS-PAGE (Figure 4). This selection step is usually performed using 
minimal media instead of the relatively rich YP medium that contains 
yeast extract and peptone of which the composition can slightly vary 
from batch to batch. The choice of YP was determined by the fact that 
with minimal medium the expression level was relatively low. SDS-
PAGE analysis of the extracts revealed overexpression of a protein 
with a molecular weight of about 68 kDa, which comes close to the 
theoretical molecular weight of HMFO (57 kDa). While the protein is 
one of the most abundant proteins in the cell extract
For most of the transformants, the expression is relatively poor when 
compared to expression of HMFO in E. coli.
As with extracellular expression SDS-PAGE, was used to identify 
a colony/transformant with the best integration site, resulting is 
secretion of HMFO. This revealed in some cases a clear overexpression 
of one particular protein (Figure 5). The observed protein seems to 
have a molecular weight that is higher (77.6 kDa) than the predicted 
molecular weight of HMFO (57 kDa) (Figure 5). Nevertheless, mass 
spectrometry (MS) analysis confirmed that the respective protein 
Figure 4. SDS-PAGE analysis of intracellular expression of HMFO by P. pastoris cells. 
The first lane is the protein ladder while the other lanes represent extracts from 
different cultures (using selected colonies).
Figure 5. SDS-PAGE analysis of extracellular expression of HMFO by P. pastoris 
cells. The first lane is the protein ladder and the rest are protein samples of cell-free 
supernatants.
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made to improve the yield of the secreted protein through optimiz-
ing culture conditions. Specifically, a different culture volume: flask 
volume ratio (1:20 instead of 1:10) to improve aeration and the addi-
tion of FAD (20 μM) in the culture were tested. Unfortunately, these 
changes did not have a significant effect. The final yield of secreted 
active protein was about 14 mg/L which is considerably lower than 
what is obtained by intracellular expression in E. coli (100-150 mg/L).
DISCUSSION
B. subtilis spore display of HMFO. Surface display of enzymes 
has several well-known advantages in addition to the unrestricted 
access of the enzyme presented on the cell surface towards externally 
added substrates. Firstly, it allows the enzyme as an immobilized one 
because because cell can be easily recovered and recycled. Secondly, 
immobilization often increases the biocatalyst thermostability, which 
is obviously beneficial for industrial processes. To achieve HMFO 
expression on the surface of B. subtilis spores, the hmfo gene was 
introduced at the C-terminus of several genes known to encode for 
coat proteins (Cot). By choosing several Cot proteins, we tried to 
identify the best performing fusion. The selected coat proteins were 
CotB, CotC, CotG, CotX and CotZ, which represent some of the most 
commonly used surface anchoring targets since they are present in 
the outer or crust portion of the spore structure [16,24]. Common 
methods to achieve protein anchoring to spore coat proteins involve 
chromosomal expression in which genetic stability is assured by 
integration of the constructs into the non-essential amyE gene [25–28]. 
These strategies result in the co-presence of both chimeric spore 
coat fusion proteins and the native anchoring spore coat proteins 
on the spore surface. In this study introduction of the hmfo gene was 
targeted directly in the chromosomal location of the targeted coat 
proteins in order to achieve a high level expression of Cot-HMFO 
fusions on the spore surface by eliminating the competitive presence 
of the native coat protein. The expression of the various Cot-HMFO 
fusions would benefit from the native chromosomal location and 
the native promoter (sporulation induced). Moreover, this strategy 
would allow combining several fusions in order to get even more 
heterologous enzyme expressed on the spore surface using several 
spore coat proteins simultaneously. The chromosomal integrations 
were achieved by taking advantage of homology cross-over recombi-
nation and the CRISPR-Cas9 system for facile selection. The cross-over 
recombination genome editing technique is widely used to obtain 
N70 and N224. MS analysis gave almost complete coverage of the 
full HMFO sequence, except for a few short sequence regions which 
did not result in peptides measured by MS. Specifically no peptide 
encompassing N70 was detected. This suggests that this amino acid 
may be glycosylated when produced as secreted protein in yeast. This 
may explain the difference in molecular weight when compared with 
non-glycosylated HMFO.
The secreted HMFO appears rather pure and can be easily obtained 
as supernatant or filtrate from a culture. Since the extracellularly 
expressed HMFO is the most interesting to explore, we tested the 
supernatant containing secreted HMFO for HMF conversions. This 
revealed that cell-free supernatants containing extracellular HMFO 
were able to convert HMF to FDCA (Figure 6). However, also the cell-
free supernatant of a control culture (wild type P. pastoris) was able to 
convert HMF (Figure 6). Interestingly, the conversions resulted in for-
mation of some 5-(hydroxymethyl)furan-2-carboxylic acid ( HMFCA). 
This oxidation product was not found in previous conversions in 
which HMFO was used. In fact, also a conversion of HMF with a 
known amount of HMFO was performed in parallel and confirmed 
that HMFO is not capable to form HMFCA. The conversions of the 
cell-free supernatants seem to be partly based on enzyme activities 
present in P. pastoris. The conversions also clearly confirm that some 
HMFO was secreted as active enzyme.
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used. In fact, also a conversion of HMF with a known amount of HMFO was 
performed in parallel and confirmed that HMFO is not capable to form 
HMFCA. The conversions of the cell-free supernatants seem to be partly based 
on enzyme activities present in P. pastoris. The conversions also clearly confirm 




Figure 5. Conversion of HMF by HMFO expressed in the supernatant (extracellular fraction) 
of P. pastoris (left part) and purified HMFO from E. coli (HMFO and HMFO+supernatant).  
 
 
Since extracellular HMFO production is attractive, attempts were made to 
improve the yield of the secreted protein through optimizing culture conditions. 
Specifically, a different culture volume : flask volume ratio (1:20 instead of 1:10) 
to improve aeration and the addition of FAD (20 μM) in the culture were tested. 
Unfortunately, these changes did not have a significant effect. The final yield of 
secreted active protein as about 14 mg/L which is considerably lower than 




















Figure 6. Conversion of HMF by HMFO expressed in the supernatant (extracel-
lular fraction) of P. pastoris (left part) and purified HMFO from E. coli (HMFO and 
HMFO+supern tant). 
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commonly used flexible linker with no defined structure [10,11,22,35–
37]. Since CotG has been successfully used in several studies, we decided 
to try several linkers for the CotG-HMFO fusions. Except for the GGGGS 
linker, a construct was made without a linker and another construct 
contained a linker with a strong α-helical motif (−GGGEAAAKGGG-). 
The latter has been used in several cases [28,30,38]. Unfortunately, 
none of the Cot-HMFO constructs seems to be effective for functional 
HMFO display on the surface of B. subtilis spores. The lack of oxidase 
activity could be explained by the location of HMFO: being fused 
to the C-terminus of the coat proteins may result in localization of 
HMFO on the inner side of the spore. Yet, it is unlikely that this occurs 
in all cases (five different coat proteins) and one would still expect 
that it would lead to HMF conversion. Another reason behind the 
failure could be that HMFO is fused too close (even in the case of the 
long α-helix linker) to the spore surface and therefore there it blocks 
access of the substrate to the active site or a conformational change is 
induced which inactivates HMFO. The crystal structure of HMFO (PDB 
4UDQ) shows that the N-terminus is quite well exposed and flexible. 
Therefore, it is unlikely that the linkage at the N-terminus would be 
a problem. Moreover, HMFO is usually expressed and purified as a 
fusion with a N-terminal His- or SUMO-tag to facilitate functional 
expression and purification. This shows that a N-terminal fusion can 
be tolerated. Other likely causes for the lack of activity is incorrect 
folding of HMFO during expression a Cot-fusion protein and/or loss 
of the FAD cofactor during the process of surface display. The surface 
display of apo HMFO may lead to unfolding, explained the inability 
to regain activity upon adding FAD.
The specific B. subtilis expression strain used in this study is B. subtilis 
DB104. This strain was selected because it is commonly used in indus-
try as it lacks the alkaline protease (aprA3) and the neutral protease 
(nprE18). Hence, it displays a low extracellular protease activity [19]. 
We were able to obtain spores for each designed construct, proving 
that the fusion of HMFO to the specific Cot proteins does not affect 
the sporulation process. The reason behind the lack of HMFO activity 
is still not clear. Optimization of the sporulation protocol by lowering 
the sporulation time (from 48 h to 24 h) and temperature (from 37 °C to 
30 °C) was explored to avoid a possible unfolding or proteolytic event. 
To limit proteolytic activity, we also tested the addition of PMSF in 
the lysozyme treatment. Yet, these precautions did not result in any 
detectable HMFO activity.
chromosomal expression [26,29,30]. Homologous recombination 
naturally occurs in B. subtilis as a bacterial strategy to perpetuate 
gene diversification and genome stability, and it can easily be used to 
achieve a targeted gene knock-in [31]. The homologous recombination 
was combined with the CRISPR-Cas9 system because the latter is a 
very efficient tool that comprises a markerless selection and facilitates 
the screening after the cross-over recombination [20]. The clustered 
regularly interspaced short palindromic repeat (CRISPR)-Cas system is 
a bacterial and archaeal adaptive immune system against phages and 
plasmids based on RNA sequence-specific detection [32]. CRISPR-Cas9 
is a particular type of system involving Cas9, an endonuclease able 
to cleave target dsDNA thanks to the base-paired structure formed 
between thetrans-activating CRISPR RNA (tracrRNA) and the targeting 
crRNA [33]. The cleavage is site specific and is led by base-pairing of 
the crRNA and the target protospacer DNA including protospacer 
adjacent motif (PAM). 
In this study we used the plasmid pJOE8999 to introduce the hmfo 
gene in frame with the genes encoding for CotB, CotC, CotG, CotX 
or CotZ [20]. This plasmid represents a shuttle vector that can be 
edited in E. coli and it does not replicate in B. subtilis allowing a sim-
ple genome editing of B. subtilis based on homology recombination 
and CRISPR-Cas9. This single-plasmid system represents a versatile 
tool for gene knock-out or knock-in purposes. The strategy based on 
homologous recombination of the Cot-HMFO fusion genes in the 
native coat locus differs from the commonly used recombination in 
the amyE locus as already mentioned in the introduction. The rationale 
for this approach was to use the native locus and promoter for Cot 
protein expression. This was thought to reduce the interference with 
the genome, that could lead to low expression levels, and to avoid the 
co-presence of chimeras and native coat proteins. The expression of a 
coat protein fusion in strains with null mutations for the targeted coat 
protein proved to be beneficial in the case of CotC [34]. The vector and 
method designed by J. Altenbuchner was an efficient and fast method 
to achieve the homologous recombination [20]. Different Cot proteins 
were targeted for two reasons: (1) to select the best performing fusion 
construct towards FDCA production, and (2) in a next step, different 
fusions could be combined to increase the amount of HMFO on the 
spores. We chose not to add a tag at the N- or C-terminus (e.g. for 
antibody detection) to avoid the risk of interfering with the protein 
folding. Moreover, because we were primarily interested in HMFO 
activity, we focused on establishing whether spores could catalyze 
the conversion of HMF to FDCA.
The linker used in case of all five coat protein was the GGGGS, a 
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CONCLUSIONS
The immobilization of HMFO through display on the surface of B. 
subtilis spores was not achieved. Attempts for establishing surface 
display of the oxidase using different coat protein anchors and linkers, 
different conditions for growth and sporulation, or addition of the 
FAD cofactor, were unsuccessful. The reason for this remains unclear 
but may be related to problems of protein folding, ineffective cofactor 
incorporation, and/or proteolysis. 
Gratifyingly, intra- and extracellular expression using P. pastoris was 
found to be feasible, leading to functional HMFO. Secretion seems a 
viable alternative for HMFO production and deserves follow-up studies 
to optimize expression and to evaluate the recombinant enzyme.
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PRIMER LIST FOR P. PASTORIS HMFO EXPRESSION





SECRETED 8BXHMFO MASS-SPECTROMETRY ANALYSIS
GBLOCK FOR P. PASTORIS HMFO EXPRESSION:
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Oxygen-containing heterocycles (O-heterocycles) form a class of 
compounds proven to be relevant in the polymers, fuel, and medical 
fields.[1–4] Some of these O-heterocycles such as lactones, and in 
particular 1,4-dioxan-2-one can be used for synthesis of biodegrad-
able polyesters that find countless clinical applications thanks to 
their biocompatibility and strength properties.[5,6] Bioabsorbable 
polymers derived from 1,4-oxathian-2-one possess similar charac-
teristics to polydioxanone, but they are not as studied and commer-
cially used, probably because of the poor yield in the synthesis of 
1,4- oxathian-2-one.[7] The chemical routes to synthetize some of 
these compounds often require expensive transition-metal catalysts 
(Au or Pd catalysts), which increase the production costs.[8] Moreover 
biodegradable polymers for biomedical applications need to be metal 
free.[9] Enzymatic synthesis of lactones as polyester building blocks 
gained great interest as an environmentally sustainable alternative 
to current chemical methods. The most common biocatalysts to 
produce lactones are Baeyer-Villiger monooxygenases (BVMOs) and 
alcohol dehydrogenases (ADHs).[10–13] These two classes of enzymes 
require cofactor NAD(P)H regeneration, making these strategies less 
suitable for commercial applications. Oxidases are an attractive class 
of enzymes for the production of bulk chemicals since they use 
oxygen either as an oxidant without the need to regenerate cofactors.
[14] Alcohol oxidases are a subclass of oxidative enzymes containing 
either a copper or flavin adenine dinucleotide (FAD) as a prosthetic 
group that often has a broad substrate spectrum, including primary 
and secondary alcohols, aldehydes, and ketones.[15] A remarkable 
example of the power of flavoprotein oxidases is the 5-hydroxymeth-
ylfurfural (HMF) oxidase discovered and engineered by our group. 
This FAD-containing biocatalyst can oxidize 5-hydroxymethylfur-
fural to 2,5-furandicarboxylic acid in three consecutive oxidations. 
[16,17] Another recent demonstration of the biocatalytic potential of 
a flavoprotein alcohol oxidase was recently reported by Turner and 
co-workers. They showed that choline oxidase can be engineered 
towards a wider substrate acceptance, for the selective oxidation of 
primary alcohols to aldehydes.[18] 
The FAD-containing alcohol oxidase from the white-rot basidio-
mycete Phanerochaete chrysosporium (PcAOX) was recently charac-
terized and engineered by our group for improved activity towards 
glycerol.[19] The rational engineering study resulted in the variant 
F101S optimized for glycerol conversion. The aim of this work was to 
explore and expand the potential of this improved variant. Herein, 
ABSTRACT
Flavoprotein oxidases can catalyze oxidations of alcohols and amines 
by merely using molecular oxygen as the oxidant, making this class of 
enzymes appealing for biocatalysis. The FAD-containing (FAD=flavin 
adenine dinucleotide) alcohol oxidase from P. chrysosporium facilitated 
double and triple oxidations for a range of aliphatic diols. Interestingly, 
depending on the diol substrate, these reactions result in formation 
of either lactones or hydroxy acids. For example, diethylene glycol 
could be selectively and fully converted into 2-(2-hydroxyethoxy) acetic 
acid. Such a facile cofactor-independent biocatalytic route towards 
hydroxy acids opens up new avenues for the preparation of polyester 
building blocks.
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kinetic parameters for these and other alcohols were determined (see 
Table 2). This data indeed confirmed that AOX* can act on aliphatic 
the attention was directed to diols which represent an industrially 
important class of chemical compounds as they are relatively cheap 
and can be transformed into either lactones or hydroxy acids, which 
in turn are building blocks for biodegradable polymers. Except for a 
focus on diols as substrates, we also tested other alcohols (primary 
and secondary) and aminoalcohols. Such a large variety of different 
substrates was explored to probe the substrate acceptance profile of 
F101S-PcAOX, but also to understand how catalyzes the double oxida-
tion of alcohols into carboxylic acids. The most striking discovery is 
the ability of F101S-PcAOX to selectively perform double oxidations 
on one of two hydroxy groups for a subset of diols.
The initial experiments were performed with a small set of diols, 
aimed to verify which variant of PcAOX (wild-type PcAOX or the 
F101S variant) was more active (see the Supporting information). NMR 
analysis proved to be the best method for analysis of these types of 
compounds. This approach is fast and it allowed a quantitative and 
qualitative analysis of the formed products. Table 1 presents the list 
of substrates tested and the product yields as determined by 1H NMR 
spectroscopy. 
The results revealed that the F101S mutant outperformed the wild-
type enzyme, which is in line with its wider active site. F101S-PcAOX 
(referred to as AOX* in the rest of the manuscript) was selected for 
further investigation.
AOX* showed activity towards the shortest tested diol (1,3-propane-
diol), but a mixture of products was obtained. The enzyme is likely to 
convert this substrate into a very active aldehyde and/or dialdehyde 
species. The substrate 1 (1,4-butanediol) was oxidized by AOX* into 
a mixture of two products: the corresponding γ-butyrolactol and 
γ-butyrolactone (Table 1). The lactol product intermediate was the 
main component and existed in the buffer environment as mixture 
of hemiacetal and hydroxylaldehyde (ratio 10:1). The unanticipated 
finding that AOX* converted 1 into the lactone (by a double oxidation) 
motivated us to perform product analysis of other aliphatic diols. The 
substrate 2 was crucial to understanding the reaction mechanism.
For 2, complete conversion was observed, resulting in the doubly 
oxidized product. This result shows that AOX* performs two consec-
utive oxidations of the primary alcohol group, even in the presence of 
a secondary alcohol moiety. The product of the double oxidation was 
obtained as mixture of the lactone form (γ-valerolactone) and the hy-
drolyzed form (4-hydroxypentanoic acid) in a ratio of 4:1. Analogous to 
the conversion of 1, the double oxidation of 2 presumably proceeds by 
formation of the corresponding lactol (5-methyltetrahydrofuran-2-ol). 
To verify the ability of AOX* to act on both compounds, the steady-state 
Table 1. Results of AOX*-catalysed conversions of diols and other alcohols [a].
Entry Substrate Intermediate Product Product [%]
1
HO




OH O OH O O >99
[b]
3 HO OH O OH HO COOH >99
4 OHO OH O
O
OH OHO COOH >99
5 SHO OH O
S
OH SHO COOH >99




7 OHHO CHOOHC COOHOHC >99[c]
8 O OHOHO O O CHOOHC O O COOHOHC >99[d]






11 OH / O 21
12 OH / O 15
13 OH / / 0
[a] Reaction conditions: substrate (20 mM), enzyme (40 µM), and 100 mM potassium 
phosphate buffer pH 7.5 for 48 h at 35 °C. Yields were determined based on 1H NMR 
spectroscopy. 1H NMR spectroscopy was performed after the addition of D2O (15% 
v/v). [b] Ratio cyclic to open product 4:1. [c] Ratio of gem-diol and aldehyde form of 
carboxylic acid (ratio ~1:1). [d] Ratio of gem-diol and aldehyde form of carboxylic 
acid (ratio~10:1).
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oxocarboxylic acids. For these two substrates the aldol condensation 
product was not obtained, probably because of the unfavorable for-
mation of a seven-membered-ring product. For the latter substrates 
(6-8), AOX* performed a triple oxidation by oxidizing the gem-diol 
form of the formed dialdehydes. NMR analysis also confirmed that 
these aliphatic aldehydes are significantly hydrated (10-50%) in the 
employed buffer. For the selective oxidation of only one hydroxy group, 
as observed for 3-5, formation of a very stable hemiacetal intermediate 
seems to be crucial. If the hemiacetal is not formed upon the first 
oxidation, the enzyme will oxidize the other hydroxy group, resulting 
in the dialdehyde. Subsequently, one aldehyde group is oxidized to 
the carboxylic acid via the gem-diol. Once that the carboxylic acid is 
obtained, the enzyme does not accept this compound for the further 
oxidation towards a diacid. Along these lines, the substrate 9 was 
found to yield hexanoic acid, supporting our hypothesis that AOX* can 
further oxidize the initially formed aldehyde via its gem-diol. Different 
from the other substrates, 9 and the intermediate product formed from 
9 (Int-9) exhibited substrate inhibition (see Table 2; see the Supporting 
Information), which may be due to alternative binding pockets for 
these relatively apolar substrates when compared with the tested diols.
The aminoalcohol (10) was used to explore the substrate promiscuity 
of AOX* (Table 1). Interestingly, complete conversion was observed for 
10. From the 1H NMR spectra it can be concluded that the reaction 
occurred as selective single oxidation on the hydroxy group. A singlet 
at d=7.88 ppm clearly indicated that the product exists as an imine 
(in situ formed spontaneously from aminoaldehyde). The 1H NMR 
spectra appeared complex and the product could not be extracted with 
ethyl acetate to confirm the product by GC-MS analysis. Nevertheless 
Braekman and coworker describe that Δ-piperideine under reaction 
conditions (pH 7.5) analogous to ours preferably dimerizes to form 
tetrahydroanabasine, which correlates with our 1H NMR spectra.[21]
It is known that alcohol oxidases can oxidize secondary alcohols, 
though with poor efficiency. We selected just a few to test AOX* (sub-
strates 11, 12, and 13; Table 1). Cyclohexanol (11) was oxidized to cyclo-
hexanone with a low yield. Initially, we tested racemic 1-phenylethanol 
and its conversion was rather low, similar to cyclohexanol. We then 
tested separately each enantiomer of this alcohol (substrates 12 and 
13). Remarkably, AOX* was highly selective towards the S-enantiomer 
of 1-phenylethanol (no conversion for the R-enantiomer).
The steady-state kinetic parameters for a selection of the discovered 
AOX* substrates were determined (Table 2). 
The observed values for 2 and its corresponding lactol (Int-2) sup-
port the proposed catalytic mechanism of the double oxidation going 
diols and the lactol (5-methyltetrahydrofuran-2-ol), demonstrating 
that the catalytic route proceeds through initial lactol formation and 
subsequent additional oxidation to the lactone. 
The substrates 3, 4, and 5 were selected as examples for 1,5-diols 
(Table 1). For all three substrates, complete conversion was obtained 
and the corresponding products of the double oxidation for these 
diols were obtained in the form of 5-hydroxycarboxylic acids as single 
products. No other products (lactone, diacid, or aldehyde acid) were 
observed by 1H NMR spectroscopy. These results are in contrast to 
the products formed with 1 and 2, which are obtained in the lactone 
form. Additional experiments were performed to explain this apparent 
difference. We investigated the stability of the commercially available 
1,4-dioxan-2-one (the lactone form of the product of substrate 4). This 
compound was found to swiftly hydrolyze in buffer (Scheme 1). In 
buffer, in less than half hour it completely hydrolyzed to the hydroxy 
acid (reaction conditions: 100 mM KPi buffer pH = 7.5; see Supporting 
Information), indicating that as soon as the lactone is formed upon 
oxidation of either 3, 4, or 5, the formed lactone rapidly hydrolyzes 
into the stable hydroxy acid. We also monitored the conversion of 4, 
thus revealing that the first detectable product intermediate exists in 
its hemiacetal form. According to these data, we conclude that the 
AOX*-catalyzed double oxidation of aliphatic diols proceeds by forma-
tion of the corresponding hemiacetal which is subsequently oxidized 
into the lactone, which is prone to hydrolysis into the corresponding 
5-hydroxy acids (Scheme 1).
The substrate 6 (Table 1) was also tested, because the corresponding 
product lactone (ε-caprolactone) is of value as a polymer building block.
[20] Somewhat unforeseen, AOX* was found to oxidize both hydroxy 
groups into aldehyde groups resulting in the production of adipalde-
hyde. In the employed buffer, adipaldehyde spontaneously reacted by 
aldol condensation (non-enzymatic reaction; see Supporting Informa-
tion) while also some further oxidation into 6-oxohexanoic acid was 
observed. Similarly, to substrate 6, 1,8-octanediol (7) and triethylene 
glycol (8) underwent oxidation at both hydroxy groups, yielding the 
corresponding dialdehydes, which were then further oxidized into 
 
Scheme 1 Catalytic route for oxidation of the 1,5-diols 3, 4 and 5 by AOX*. X=C, 
S, or O.
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In conclusion, this work demonstrates the potential of AOX* as a 
biocatalyst to produce, in one pot, hydroxy acids from 1,5-diols through 
a selective double oxidation. Diethylene glycol and thiodiglycol can 
be converted into the corresponding hydroxy acids, which represent 
interesting building blocks for biodegradable polymers. Similarly, 
1,4-diols are converted into the respective lactones. The final oxidation 
products obtained, γ-butyrolactone and γ-valerolactone are used in the 
polymer industry.[4] [25] The catalytic mechanism of AOX* with these 
diols involves the in situ formation of stable hemiacetals. Longer diols 
can also be oxidized by AOX*, resulting in the corresponding oxocar-
boxylic acids through a triple oxidation. For all these AOX*-catalyzed 
oxidation cascade reactions, no external cofactor is required. These 
results suggest that AOX* holds a great promise as a biocatalyst for 
selective oxidations.
EXPERIMENTAL SECTION
AOX* was expressed in E. coli NEB 10β as His-tag-SUMO phusion using 
a pBAD expression vector and purified using affinity chromatography 
as described before.[19] Kinetic parameters were determined using 
a HRP-coupled assay as described before.[19] 1H NMR spectra were 
recorded on an Agilent 400-MR spectrometer (1H and 13C resonances 
at 400 MHz and 100 MHz, respectively). Chemical shifts are reported 
in parts per million (ppm) and coupling constants (J) are reported in 
hertz (Hz). 
through the lactol intermediate. The rate-limiting step (lower kcat/
KM) seems to be the second oxidation step, the oxidation of the lactol. 
This step was confirmed for substrate 1 and also by shorter conversion 
experiments for substrates 2-5. Shorter incubations revealed the ac-
cumulation of the respective lactols.
The substrates 4 and 5 were also tested as substrates with several 
other flavoprotein alcohol oxidases: alditol oxidase (HotAldO) from 
Acidothermus cellulolyticus 11B, chitooligosaccharide oxidase (ChitO) 
from Fusarium graminearum, 5-hydroxymethylfurfural oxidase (HMFO) 
wild type and variant 8BxHMFO from Methylovorus sp. strain MP688, 
methanol oxidase from Hansenula sp. (EC 1.1.3.13), glucose oxidase 
form Aspergillus niger (EC 1.1.3.4), and choline oxidase wild-type and an 
engineered choline oxidase variant (AcCO6) from Arthrobacter chloro-
phenolicus. [16,17,22–24] Except for (AcCO6), all these oxidases did not 
convert 4 and 5. The six-fold mutant of choline oxidase, AcCO6, proved 
to facilitate the double oxidation of 4 and 5, albeit with low yields: 5% 
product (38% lactol intermediate) with 4, and 28% of product (68% 
lactol intermediate) with 5, using the same reaction conditions as with 
AOX*. Furthermore, AcCO6 was found to suffer from severe substrate 
inhibition. 
Table 2. Apparent Steady-State Kinetic Parameters for AOX*[a]. 
Entry Substrate KM[a] Ki[b] kcat[a] kcat/KM
1
HO
OH 198 n.d. 6.74 34.1
2
OH
OH 52.6 n.d. 1.28 24.3
Int-2 O OH 95.5 n.d. 1.13 11.8
3 HO OH 69.6 n.d. 3.48 50.0
4 OHO OH 12.3 n.d. 0.73 59.2
5 SHO OH 119 n.d. 3.56 29.9
6 HO OH 12.9 n.d. 4.07 316
9 OH 3.0 56 0.56 187
Int-9 CHO 0.20 5.5 0.15 750
[a] Values obtained using the HRP-coupled assay in 50 mM potassium phosphate, 
pH 7.5. KM values are presented in units of mM, kcat values are presented in units of s-1, 
and kcat/KM values are presented in units of M-1 s-1. [b] The notation n.d. (not detected) 
used to indicate that no substrate inhibition was observed.
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ENZYMATIC REACTION OF SUBSTRATES AND ANALYSIS OF 
PRODUCTS
Each reaction mixture contained 20 mM substrate, 40 μM enzyme 
in 100 mM KPi buffer, pH 7.5 (final reaction volume was 0.4 mL). The 
reaction was performed in a closed 4 mL glass vial at 35 °C during 24 or 
48 h. After that, the reaction was diluted by adding 100 μL of D2O (20% 
v/v) and the product was analyzed by 1H NMR without further purifi-
cation. Yields were determined based on 1H NMR. All the reactions 
were done in duplicates. The control reaction was performed under 
the same reaction conditions without adding alcohol oxidase.
SUPPORTING INFORMATION
Kinetic analyses. The employed assay measures the reaction rate 
thanks to the hydrogen peroxide generated by AOX during the sub-
strate conversion. Hydrogen peroxide is used by HRP (horse radish 
peroxidase) (40 U/mL) to catalyze the oxidative coupling reaction of 
4-aminoantipyrine (0.1 mM) and 3,5-dichloro-2-hydroxybenzenesul-
fonic acid (1.0 mM). This reaction results in the formation of a pink 
quinoid product that can be detected and quantified using a spectro-
photometer (ε515 =26 mM−1cm−1). The KM values are presented in mM, 
kcat values are presented in s−1, and kcat/KM values are presented in 
M−1 s−1. For obtaining KM and kcat values, the data were fit using a regular 
Michaelis-Menten equation: kobs=kcat*[S]/KM + [S]. 
In the case of observed substrate inhibition, the following modified 
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Substrate 2 (1,4-pentanediol)
Substrate 2 (1,4-pentanediol) 1H NMR (400 MHz, D2O) δ 3.70 (h, J = 6.2 Hz, 1H), 3.46 
(t, J = 6.4 Hz, 2H), 1.53 – 1.30 (m, 4H), 1.02 (d, J = 6.4 Hz, 3H).
Substrate 2 (5-methyltetrahydrofuran-2-ol – major isomer) 1H NMR (400 MHz, D2O) δ 
5.36 (dd, J = 5.2, 2.6 Hz, 1H), 4.19 (dd, J = 12.3, 6.3 Hz, 1H), 2.11 – 1.93 (m, 2H), 1.72 – 1.59 
(m, 1H), 1.42 – 1.30 (m, 1H), 1.05 (d, J = 6.3 Hz, 3H).
Product 2 (γ-valerolactone) 1H NMR (400 MHz, D2O) δ 2.58 – 2.41 (m, 2H), 2.32 – 2.21 
(m, 1H), 1.84 – 1.65 (m, 1H), 1.24 (d, J = 6.2 Hz, 3H).
NMR SPECTRA
Substrate 1 (1,4-butanediol)
Substrate 1 (1,4-butanediol) 1H NMR (400 MHz, D2O) δ 3.63 – 3.34 (m, 2H), 1.60 – 1.31 
(m, 2H).
Substrate 1-int (tetrahydrofuran-2-ol) 1H NMR (400 MHz, D2O) δ 5.35 (dd, J = 4.8, 1.8 
Hz, 1H), 3.85 (dt, J = 7.9, 5.2 Hz, 1H), 3.67 (dd, J = 7.9, 7.0 Hz, 1H), 1.93 – 1.64 (m, 4H).
Product 1 (γ-butyrolactone) 1H NMR (400 MHz, D2O) δ 4.29 (t, J = 7.2 Hz, 2H), 2.43 (d, 
J = 8.0 Hz, 2H), 2.18 – 2.08 (m, 2H).
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Substrate 4 (diethylene glycol)
Substrate 4 (diethylene glycol) 1H NMR (400 MHz, D2O) δ 3.61 – 3.57 (m, 4H), 3.51 – 
3.47 (m, 4H).
Product 4 (2-(2-hydroxyethoxy)acetic acid) 1H NMR (400 MHz, D2O) δ 3.80 (s, 2H), 
3.61 – 3.56 (m, 2H), 3.50 – 3.45 (m, 2H).
Substrate 3 (1,5-pentanediol)
Substrate 3 (1,5-pentanediol) 1H NMR (400 MHz, D2O) δ 3.46 (t, J = 6.6 Hz, 4H), 1.41 
(p, J = 7.0 Hz, 4H), 1.27 – 1.17 (m, 2H).
Product 3 (5-hydroxypentanoic acid) 1H NMR (400 MHz, D2O) δ 3.46 (t, J = 6.2 Hz, 
2H), 2.05 (t, J = 7.0 Hz, 2H), 1.48 – 1.35 (m, 4H).
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Substrate 6 (1,6-hexanediol)
Substrate 6 (1,6-hexanediol) 1H NMR (400 MHz, D2O) δ 3.45 (t, J = 6.6 Hz, 4H), 1.39 
(p, J = 6.7 Hz, 4H), 1.23 – 1.17 (m, 4H).
Substrate 6-int (6,6-dihydroxyhexanal) 1H NMR (400 MHz, D2O) δ 9.52 (s, 1H), 4.89 (t, 
J = 5.6 Hz, 1H), 2.46 – 2.37 (m, 2H), 1.54 – 1.41 (m, 4H), 1.30 – 1.19 (m, 2H).
Product 6a (cyclopent-1-ene-1-carbaldehyde) 1H NMR (400 MHz, D2O) δ 9.50 (s, 1H), 
7.07 (bs, 1H), 2.55 – 2.46 (m, 2H), 2.39 – 2.28 (m, 2H), 1.92 – 1.77 (m, 2H).
Product 6b 1H NMR (400 MHz, D2O) δ 9.52 (s, 0.5H), 4.88 (t, J = 5.3 Hz, 0.5H), 2.44 – 2.37 
(m, 1H), 2.04 (td, J = 7.2, 3.1 Hz, 2H), 1.51 – 1.37 (m, 4H), 1.27 – 1.16 (m, 1H).
Substrate 5 (thiodiglycol)
Substrate 5 (thiodiglycol) 1H NMR (400 MHz, D2O) δ 3.60 (t, J = 6.3 Hz, 4H), 2.60 (t, 
J = 6.2 Hz, 4H).
Product 5 (2-((2-hydroxyethyl)thio)acetic acid) 1H NMR (400 MHz, D2O) δ 3.60 (t, J = 
6.3 Hz, 2H), 3.07 (s, 2H), 2.58 (t, J = 6.3 Hz, 2H).
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Substrate 8 (triethylene glycol)
Substrate 8 (triethylene glycol) 1H NMR (400 MHz, D2O) δ 3.60 – 3.57 (m, 4H), 3.56 
(s, 4H), 3.52 – 3.48 (m, 4H).
Product 8 (2-(2-(2,2-dihydroxyethoxy)ethoxy)acetic acid)  1H NMR (400 MHz, D2O) δ 
5.03 (t, J = 5.0 Hz, 1H), 3.80 (s, 2H), 3.61 – 3.47 (m, 4H), 3.37 (d, J = 5.0 Hz, 2H).
Substrate 7 (1,8-octanediol)
Substrate 7 (1,8-octanediol) 1H NMR (400 MHz, D2O) δ 3.44 (t, J = 6.7 Hz, 4H), 1.43 – 1.35 
(m, 4H), 1.21 – 1.13 (m, 8H).
Product 7 (8-oxooctanoic acid) 1H NMR (400 MHz, D2O) δ 9.51 (s, 0.5H), 4.88 (t, J 
= 5.6 Hz, 0.5H), 2.37 (t, J = 7.4 Hz, 1H), 2.02 (t, J = 7.4 Hz, 2H), 1.51 – 1.35 (m, 4H), 
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Substrate 9 (1-hexanol)
Substrate 9 (1-hexanol) 1H NMR (400 MHz, D2O) δ 3.44 (t, J = 6.7 Hz, 2H), 1.38 (p, J = 
5.8 Hz, 2H), 1.22 – 1.11 (m, 6H), 0.75 – 0.67 (m, 2H).
Product 9 (hexanoic acid) 1H NMR (400 MHz, D2O) δ 2.01 (t, J = 7.4 Hz, 2H), 1.39 (p, J 
= 7.2 Hz, 2H), 1.25 – 1.05 (m, 4H), 0.71 (t, J = 6.8 Hz, 2H).
Substrate 10 (5-amino-1-pentanol)
Substrate 10 (5-amino-1-pentanol) 1H NMR (400 MHz, D2O) δ 3.46 (t, J = 6.5 Hz, 2H), 
2.85 (d, J = 6.8 Hz, 2H), 1.53 (p, J = 7.6 Hz, 2H), 1.47 – 1.38 (m, 2H), 1.32 – 1.20 (m, 2H).
Product 10 (5-(piperidin-2-yl)-2,3,4,5-tetrahydropyridine) 1H NMR (600 MHz, D2O) 
δ 7.97 (s, 1H), 3.89 (t, J = 5.9 Hz, 2H), 3.82 (t, J = 6.2 Hz, 2H), 3.16 (t, J = 6.3 Hz, 2H), 
2.78 (t, J = 6.4 Hz, 2H), 2.62 (t, J = 6.5 Hz, 2H), 2.58 (t, J = 7.6 Hz, 2H), 1.93 – 1.88 (m, 
2H), 1.80 – 1.69 (m, 2H).
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Substrate 11 (cyclohexanol)
Substrate 11 (Cyclohexanol) 1H NMR (400 MHz, D2O) δ 3.52 – 3.42 (m, 1H), 1.78 – 1.66 
(m, 2H), 1.61 – 1.51 (m, 2H), 1.43 – 1.32 (m, 1H), 1.19 – 0.91 (m, 5H).
Product 11 (Cyclohexanone) 1H NMR (400 MHz, D2O) δ 2.23 (t, J = 6.6 Hz, 4H), 
1.75 – 1.64 (m, 4H), 1.58 – 1.52 (m, 2H).
Substrate 12 and 13 ((S or R)-1-phenylethan-1-ol)
Substrate 12 and 13 ((S or R)-1-phenylethan-1-ol) 1H NMR (400 MHz, D2O) δ 7.36 – 7.15 
(m, 5H), 4.50 – 4.35 (m, 1H), 1.32 (d, J = 6.6 Hz, 3H).
Product 12 and 13 (Acetophenone) 1H NMR (400 MHz, D2O) δ 7.86 (d, J = 7.7 Hz, 2H), 
7.55 (t, J = 7.5 Hz, 1H), 7.41 (t, J = 7.6 Hz, 2H), 2.52 (s, 3H).
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Effective synthetic procedures for the synthesis of optically pure alco-
hols are highly valuable. A commonly employed method involves the 
biocatalytic reduction of prochiral ketones. This is typically achieved 
using nicotinamide cofactor-dependent reductases. In this work we 
demonstrate that a rather unexplored class of enzymes can also be 
used for this. We used an F420-dependent alcohol dehydrogenase 
(ADF) from Methanoculleus thermophilicus which was found to reduce 
various ketones into enantiopure alcohols. The respective S-alcohols 
were obtained in excellent enantiopurity (>99% e.e.). Furthermore, we 
discovered that the deazaflavoenzyme can be used as a self-sufficient 
system by merely using a sacrificial cosubstrate (isopropanol) and 
a catalytic amount of cofactor F420 or the unnatural cofactor FOP to 
achieve full conversions. This study reveals that deazaflavoenzymes 
complement the biocatalytic toolbox for enantioselective ketone 
reductions.
INTRODUCTION
The biocatalytic production of chiral alcohols is feasible by employing 
different classes of enzymes: oxidoreductases (EC 1), hydrolases (EC 3), 
and lyases (EC 4).[1] Several methods allow for the production of chiral 
alcohols and an effective method involves the enantioselective reduc-
tion of prochiral ketones by alcohol dehydrogenases (ADHs). ADHs 
have gained great interest due to their enantioselectivity, allowing 
for the development of many biotechnological applications.[2] The 
applicability of ADHs is somewhat limited due to their cofactor de-
pendence: most ADHs rely on the nicotinamide cofactors NADH or 
NADPH for performing reductions.[3] Often, cofactor regeneration is 
achieved by using an enzyme-coupled process.[4] We explored another 
type of ADH: an F420-dependent ADH. Such type of ADH had never 
been explored for biocatalytic reductions of ketones. The deazaflavin 
cofactor F420 was discovered in 1972, first in methanogens and later 
also in actinobacteria and other bacteria.[5–7] The redox active part 
of the cofactor resembles the isoalloxazine ring of the canonical flavin 
cofactors (Figure 1). The differences are the lack of the N5, different 
groups on the benzylic moiety, and the poly-γ-glutamate lactyl tail 
instead of the adenine part of FAD. The absence of N5 (a carbon in-
stead) dictates that the cofactor is an obligatory hydride transfer agent, 
similar to the nicotinamide cofactors. The F420 cofactor displays an 
absorption maximum at 420 nm, hence its name. The redox potential 
of this redox cofactor is exceptionally low: –380 mV (220 mV for FAD 
and –320 mV NAD(P)).[5] 
While flavin and nicotinamide cofactors are readily available to-
gether with a huge number of enzymes utilizing these cofactors, the 
biocatalytic exploration of F420-dependent is lagging behind. This is 
partly due to the fact that the deazaflavin cofactor was difficult to 
obtain. The deazaflavin cofactor can be isolated from F420-producing 
Figure 1 Structural formula of the F420 deazaflavin cofactor. Also, other deazaflavins 
are indicated: FO and FOP.
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microbes, such as Mycobacterium smegmatis. Although it involves a 
laborious process and yields small amounts, it is nowadays available 
for biocatalytic studies. Furthermore, we have recently demonstrated 
that a truncated version of the cofactor, lacking the poly-γ-glutamate 
lactyl tail (FOP, see Figure 1), is also accepted as cofactor by F420-depen-
dent enzymes.[8] FOP represents an unnatural deazaflavin cofactor 
for which a relatively easy synthetic procedure has been developed. 
Another bottleneck for using F420-dependent enzymes has been the 
lack of knowledge of and access to such biocatalysts. Particularly, these 
redox enzymes seem promising for performing selective reductions 
by virtue of the unique low redox potential deazaflavin cofactor. This 
would require regeneration of the reduced deazaflavin cofactor. This 
demand for F420H2-regenerating enzymes has been satisfied by the 
recent discovery of several deazaflavoenzymes. Especially the avail-
ability of several F420-dependent glucose-6-phosphate dehydrogenases 
is attractive for this.[9]
In the last decade the interest in exploring deazaflavoenzymes for 
biocatalysis has increased.[10,11] F420-dependent enzymes were shown 
to be involved in the production of antibiotics, and could be used for 
the asymmetric reduction of prochiral imines and enones.[12–15] In 
this work we explored an F420-dependent ADH (ADF) for its ability to 
perform enantioselective reductions of prochiral ketones. The F420- 
dependent alcohol dehydrogenase from Methanoculleus thermophilicus 
was chosen for this. ADF is a relatively small enzyme (37 kDa) which 
was first described in 1989. It can be recombinantly produced in 
Escherichia coli and its crystal structure has been elucidated.[12,16] 
Previously it was shown that ADF converts small aliphatic secondary 
alcohols into ketones. It was shown that during this oxidation step a 
hydride is transferred in a stereoselective manner from the alcohol to 
the Si-face of the F420 cofactor (to the C5 atom). It was demonstrated 
that the enzyme is able to oxidize isopropanol to acetone and the re-
verse reaction.[12] This was a clear indication that the enzyme may act 
as an enantioselective ketone reductase through an enantioselective 
hydride transfer.[16]
MATERIALS AND METHODS
Reagents and chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO, USA) unless indicated otherwise. 
F420 production. F420 was isolated from Mycobacterium smegmatis as 
described before.[17] The production strain M. smegmatis mc2 4517 
was a kind gift from Dr. G. Bashiri from the University of Auckland, 
New Zealand. 
Expression and purification of F420-dependent ADF and FGD. 
An Adf-encoding gene fragment was ordered codon optimized for 
Escherichia coli and cloned into a pBAD to have the construct expressed 
with a C-terminal His-tag. Expression was performed using Escherichia 
coli NEB 10β. Cells carrying the plasmid were grown in Terrific broth 
(TB) supplemented with 50 μg mL-1 ampicillin until OD600 was 0.8 and 
expression was induced with L-arabinose 0.02% at 24 °C overnight. 
Cells were harvested by centrifugation at 5000 × g for 20 min at 4 °C. 
Cell pellets were resuspended in 250 mM sodium phosphate buffer 
pH 7.0 containing 1 mM phenylmethylsulfonyl fluoride and 10% v/w 
glycerol. The cells were lysed by sonication, using a Sonics Vibra-Cell 
VCX 130 sonicator with a 3 mm stepped microtip (5s on, 5s off, 70 % am-
plitude, 7 min). Cell debris were pelleted by centrifugation at 12000 × g 
for 20 min at 4 °C. The supernatant was applied to Ni-Sepharose High 
Performance (GE Healthcare) pre-equilibrated with 250 mM sodium 
phosphate pH 7.0, 10% v/w glycerol. The washing buffer was 250 mM 
sodium phosphate pH 7.0, 10% v/w glycerol, 10 mM imidazole and 
the elution buffer was 250 mM sodium phosphate pH 7.0, 10% v/w 
glycerol, 500 mM imidazole. The eluted protein was desalted using a 
desalting column pre-equilibrated with 250 mM sodium phosphate 
pH 7.0, 10% v/w glycerol. FGD was purified as previously described. 
[9] Purity of ADF and FGD was assessed with SDS-PAGE analysis and 
protein concentrations were measured by using the Bradford assay.
Conversions of ketones. For ketone reductions, reaction mixtures 
contained 200 µL of 250 mM sodium phosphate pH 7.0, 10% glycerol, 
1% DMSO, 2.0 mM substrate, 2.0 mM ethyl benzene (internal standard), 
20 µM ADF, 40 µM F420 or 40 µM FOP, and 200 mM isopropanol or 20 mM 
glucose-6-phosphate with 10 µM FGD. The reaction was performed in 
a 1.5 mL Eppendorf tube in an Eppendorf Thermomixer at 25 °C and 
500 rpm for 24 h. The reaction was extracted twice using 200 µL of 
ethyl acetate. The reactions passed over anhydrous magnesium sulfate 
and finally analyzed using GC (details in the Supporting Information). 
Substrate docking. Molecular docking was performed in YASARA 
Structure (version 19.12.14). [18] The crystal structure of ADF (1.8 Å 
resolution; PDB 1RHC [16]) was used. Substrates were built using 
YASARA, energy minimization was performed, and VINA was em-
ployed to perform the docking. [19] Docking was accomplished using 
the docking simulation macro ‘dock_run.mrc’ with a 5 Å cube cell size 
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around the C5 atom of F420, 100 runs, 2 Å cluster RMSD and using the 
YAMBER forcefield. [20] YASARA was used to visualize the results. 
Pymol was used for preparing the figures.
Steady-state activity assays for F420-dependent alcohol dehydro-
genase ADF with isopropanol. The employed assay measures the 
rate at which F420 is reduced (ε400 =25.7 mM−1cm−1). The buffer used was 
250 mM sodium phosphate (pH 7.0), 10% v/w glycerol. For obtaining 
KM and kcat values, the data were fit using a regular Michaelis-Menten 
equation: kobs=kcat*[S]/KM + [S]. Data in the Supporting Information.
Isopropanol tolerance assay. The tolerance of ADF towards isopro-
panol was probed by measuring its apparent melting temperature by 
ThermoFluor. [21] Using a real-time PCR the temperature at which ADF 
unfolds in the presence of different concentrations of isopropanol was 
measured. For the measurements, 250 mM sodium phosphate pH 7.0, 
10% glycerol, 1x Sypro Orange, and 10 µM ADF was used. Data in the 
Supporting Information.
RESULTS AND DISCUSSION
Substrate exploration. First, we explored the substrate scope of ADF 
to find out whether it is able to accept alcohols different from isopropa-
nol. Alcohol oxidation activity could be easily monitored by measuring 
the decrease of absorbance of F420 (the reduced form does not absorb 
at 420 nm). ADF did not convert the following alcohols: 2-heptanol, 
5-amino-1-pentanol, 1-amino-2-propanol, 3-chloro-1,2-propanediol, 
1-phenyl-1,2-ethanediol, 1-indanol, acetoin, carveol, cyclohexylmeth-
anol, tetrahydropyran-2-methanol, 3-butyn-2-ol. Nevertheless, we 
could identify a set of aromatic and aliphatic alcohols that were not 
reported before as substrate of ADF. The corresponding ketones were 













Figure 2. Ketones used for the biocatalytic exploration of ADF.
Conversions using F420-dependent glucose-6-phosphate dehydro-
genase to regenerate F420. For the first test conversions, we used the 
F420-dependent glucose-6-phosphate dehydrogenase (FGD) from Rhodo-
ccocus jostii RHA1 (FGD) together with ADF (Scheme 1a).[9] Gratifyingly, 
it was found that the enzyme was able to fully and stereoselectively 
reduce methyl ketones to the corresponding (S)-alcohols. For most 
ketones, excellent enantioselectivity was observed (>99% e.e.), except 
for substrate 3 (92% e.e.) and substrate 6 (racemic product) (Table 1).
Substrates docking. In silico docking studies were performed to un-
derstand the molecular basis for the (S)-stereoselectivity of ADF. For 
acetophenone (1) and methoxyacetone (5) docking suggested that the 
structurally favorable product is in both cases indeed the S-enantiomer. 
This can be explained by examining the role and position of the active- 
site residues. Previous studies postulated that His39, Trp43, Glu12 and 
Glu108 are crucial for substrate binding and catalysis.[16] In the reduc-
tion reaction, a hydride transfer from the C5 atom of F420H2 to the ketone 
carbon with a simultaneous or stepwise proton addition from His39 to 
the ketone oxygen occurs. Hence, the specific orientation of substrate 
Scheme 1. Coupled reactions for the reduction of prochiral ketones by ADF. ADF: 
F420-dependent alcohol dehydrogenase, FGD: F420-dependent glucose-6-phosphate 
dehydrogenase. (a) D-glucose-6-phosphate is used by FGD to regenerate F420H2. (b) 
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5towards the F420 cofactor and His39 is decisive in the enantioselective 
outcome of the reaction. Docking of acetophenone revealed that Trp43 
together with Val193, Trp229, Trp246, Cys249 and Phe255 form a hydro-
phobic pocket which snugly accommodates the aromatic ring of the 
substrate (Figure 3). As a result, acetophenone binds in the active site 
in such a way that only the (S)-enantiomer can be formed: the hydride 
can only be transferred to the Re-face of the substrate. Positioning of 
acetophenone necessary to form the (R)-enantiomeric alcohol is pre-
vented because its aromatic ring cannot be accommodated in the active 
site in any other conformation. Docking of methoxyacetone resulted in 
an analogous optimal binding pose in which the apolar pocket next to 
the deazaflavin cofactor plays a crucial role in positioning the substrate 
such that hydride attack will occur on the Re-face of the substrate, as-
sisted by proton transfer by His39. This will, again, only allow formation 
of (S)-1-methoxy-2-propanol, as experimentally observed.




Conversion (%) e.e. (%)
1EF420 1 F420 FGD 96 >99 (S)
1IF420 1 F420 - 95 >99 (S)
1IFop 1 FOP - 5 n.d.*
2EF420 2 F420 FGD 77 >99 (S)
2IF420 2 F420 - 80 >99 (S)
2IFop 2 FOP - 3 n.d.*
3EF420 3 F420 FGD >99 92 (S)
3IF420 3 F420 - >99 72 (S)
3IFop 3 FOP - 94 >99 (S)
4EF420 4 F420 FGD 87 >99 (S)
4IF420 4 F420 - 93 >99 (S)
4IFop 4 FOP - 2 n.d.*
5EF420 5 F420 FGD >99 >99 (S)
5IF420 5 F420 - >99 >99 (S)
5IFop 5 FOP - >99 >99 (S)
6EF420 6 F420 FGD >99 0
6IF420 6 F420 - >99 0
6IFop 6 FOP - >99 0
[a] Values obtained using 250 mM sodium phosphate pH 7.0, 10% glycerol, 1% DMSO, 
2.0 mM substrate, 2.0 mM ethyl benzene (internal standard), 20 µM ADF, 40 µM F420 
or 40 µM FOP. [b] For cofactor regeneration, 20 mM glucose-6-phosphate with 10 µM 
FGD (‘FGD’) or 200 mM isopropanol (‘-‘) was used. Details are in the Supporting 
Information. *Conversions were too low for an accurate determination of e.e.
CONVERSIONS USING ISOPROPANOL AS COSUBSTRATE TO 
REGENERATE F420
The second aim of this work was to establish an efficient cofactor 
regeneration system. While the used glucose-6-phosphate dehydro-
genase is effective in recycling F420H2, such cofactor regeneration 
system still requires an addition enzyme and a relatively expensive 
cosubstrate. Therefore, we explored whether ADF can be used as 
reductase and dehydrogenase in one pot, using a sacrificial alcohol 
as cosubstrate. For this, we tested the use of isopropanol as it had 
been reported to be a good ADF substrate. In order to determine the 
highest concentration of isopropanol tolerated in conversions, we 
first assessed the thermostability of ADF in the presence of different 
amounts of isopropanol and its kinetic parameters with isopropanol. 
ADF was found to be relatively tolerant towards isopropanol with only 
a slight change in apparent melting temperature up to 200 mM isopro-
panol (Tm varied from 57.5 to 56.0 °C, see Supporting Information). The 
steady-state kinetic analysis confirmed that isopropanol is an effective 
substrate with a KM value of 1.26 mM and a kcat of 1.68 s-1 (see Sup-
porting Information). A concentration of 200 mM of isopropanol was 
selected to probe it as cosubstrate for the ADF-catalyzed reduction of 
prochiral ketones. Remarkably, the use of isopropanol as cosubstrate 
worked extremely well. In fact, there was no difference between the 
use of glucose-6-phosphate dehydrogenase and glucose-6-phosphate 
or merely isopropanol for cofactor regeneration (Table 1). This shows 
that the use of isopropanol as coupled substrate is a valid and simple 
alternative to use ADF as enantioselective ketone reductase.
Conversions using FOP as alternative cofactor. Finally, we also 








Figure 3. Binding pose of acetophenone (1) in ADF (PDB:1RHC). Left: overall struc-
ture of ADF with docked substrate (cyan) and F420 (orange) highlighted in sticks. 
Right: close-up of binding of acetophenone.
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cofactor: FOP. We have recently shown that FOP can be prepared in 
a relatively easy manner and is often accepted by F420-dependent en-
zymes. The results obtained using FOP as alternative cofactor with 
ADF and isopropanol as cosubstrate revealed that ADF can also operate 
with this alternative deazaflavin (Table 1). Yet, the use of FOP resulted 
in lower conversions for some of the ketones tested, while the enan-
tioselectivity was largely retained. The inferior performance, when 
compared with F420, probably reflects a poor recognition of FOP by ADF.
CONCLUSIONS 
In conclusion, the finding that ADF can reduce various prochiral 
ketones in a highly (S)-stereoselective manner unveils a new biocat-
alytically relevant class of enzymes: F420-dependent ketone reduc-
tases. They can be regarded as alternatives to nicotinamide cofactor- 
dependent enzymes. Moreover, we demonstrate that isopropanol can 
be used as cheap cosubstrate for cofactor recycling, rendering ADF 
self-sufficient. With the crystal structure of ADF available and many 
genes encoding for ADF homologs in the genome sequence database, 
it will be exciting to explore other variants for more demanding 
selective reductions.
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SUPPORTING INFORMATION




















Analyzed using: Agilent Technologies 7890A GC system with column 
CP Chiralsil Dex CB (Agilent). Program: 40 °C to 130 °C in 5 min, hold 
130 °C 10 min, 130 °C to 180 °C in 10 min, hold 180 °C in 5 min.
SUBSTRATE 2
Analyzed using: Agilent Technologies 7890A GC system with column 
CP Chiralsil Dex CB (Agilent). Program: 40 °C to 130 °C in 5 min, hold 
130 °C 10 min, 130 °C to 180 °C in 10 min, hold 180 °C in 5 min. 
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SUBSTRATE 3 
Analyzed using: Agilent Technologies 7890A GC system with column 
CP Chiralsil Dex CB (Agilent). Program: 40 °C to 120 °C in 3 min, 120 °C 
to 40 °C in 10 min. 
SUBSTRATE 4 
Analyzed using: Agilent Technologies 7890A GC system with column 
CP Chiralsil Dex CB (Agilent). Program: 40 °C to 140 °C in 5 min, 140 °C 
to 40 °C in 10 min. 
SUBSTRATE 5
Analyzed using: Agilent Technologies 7890A GC system with column 
FS-Hydrodex-B-TBDAc (Aurora Borealis) Program: 40 °C to 190 °C in 
5 min, 190 °C to 40 °C in 10 min.
SUBSTRATE 6
Analyzed using: Agilent Technologies 7890A GC system with column 
FS-Hydrodex-B-TBDAc (Aurora Borealis) Program: 40 °C to 190 °C in 






Work described in this thesis focused on studying and developing 
flavo- and deazaflavoenzymes in the context of biocatalysis. In recent 
years, biocatalytic oxidations perfomed by flavin-dependent enzymes 
have gained great interest in academia and industry. Some flavoprotein 
oxidases are well-known and widely applied in biotechnology. Yet, 
there are many flavoprotein oxidases that have never been considered 
for biocatalysis. Based on structural features, flavoprotein oxidases can 
be classified into six distinct families as described in Chapter 1. Even 
though they are redox enzymes, flavoprotein oxidases are relatively 
easy to use as they do not require the use of expensive cofactors or 
cofactor regeneration systems. They harbor a tightly bound flavin 
cofactor and merely rely on molecular oxygen (O2) as electron acceptor. 
Their applications include synthesis of valuable compounds and use in 
biosensors. Several oxidase examples of the GMC-type oxidase family 
are been described in detail to provide a more exhaustive view on their 
applications, but also of the process and the purposes for which these 
enzymes have been engineered in recent years. 
Chapter 2 reports on the engineering of the FAD-containing HMF- 
oxidase (HMFO) towards improved thermostability. HMFO from Meth-
ylovorus sp. strain MP688 was discovered in 2014 and represents an 
effective biocatalyst for the production of FDCA from HMF. In fact, it is 
the only known enzyme that is able to perform efficiently such a triple 
oxidation of HMF. In a previous study HMFO was already optimized to 
produce FDCA by molding the active site in order to improve the last 
and rate-limiting oxidation step. Unfortunately, this optimized variant, 
despite a good catalytic performance, displayed a relatively low ther-
mostability. This chapter describes the work performed that resulted 
in a HMFO variant with a high thermostability. For generating more 
thermostable enzyme variants, a computational protocol, FRESCO, has 
been developed. This in silico method uses a protein structure and, us-
ing protein folding free-energy calculations and molecular dynamics 
simulations, predicts mutations that should render the target protein 
more thermostable. The FRESCO-predicted point mutations for HMFO 
were tested in the laboratory which yielded a number of relatively 
thermostable mutants. In a next step, the stabilizing mutations were 
combined in order to create a highly thermostable HMFO variant. For 
identifying the best combination of mutations, a novel gene shuffling 
method was developed. The identified thermostable HMFO variant 
displayed a melting temperature that is 12 °C higher than that of the 
wild-type enzyme. By including the mutations that are beneficial for 
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catalyzing the last oxidation step leading to FDCA, the final variant 
(8BxHMFO) was obtained which was shown to result in significantly 
higher conversions of HMF info FDCA. 
Another study to improve the applicability of HMFO is described in 
Chapter 3. The aim was to optimize the heterologous expression of 
the enzyme, making its production and application more efficient. To 
achieve this, two strategies were pursued.
The first approach to improve the efficiency of HMFO utilization was 
to immobilize the biocatalyst using an in vivo system. B. subtilis was 
selected for its ability to sporulate. The generated spores can display 
a biocatalyst that it is fused with a spore-coat protein. HMFO-fusions 
were designed to obtain stable expression by genomic integration of 
8BxHMFO fused with 5 different spore-coat proteins. The hmfo was 
integrated in the genome of B. subtilis in a target locus by homology 
recombination and the screening was facilitated by CRISPR-Cas9 selec-
tion. Integration was efficient, but for all generated variants there was 
either no expression or no expression of active HMFO. Optimization 
efforts were directed on helping HMFO folding by adding FAD and on 
spore treatment optimization. Further investigation is necessary to 
establish the cause of absence of expression/activity. Most probably 
misfolding is causing the observed issues.
The second approach to improve heterologous expression of HMFO 
was by secretion using the yeast Pichia pastoris. P. pastoris is known 
for allowing, in some cases, high level production of secreted proteins. 
The expression of HMFO in P. pastoris was accomplished by genomic 
integration of a cassette containing an antibiotic resistance gene for 
selection, a methanol-regulated promoter and the 8BxHMFO-encod-
ing sequence with or without the alpha-mating factor for secretion 
or intracellular expression. Both expression systems were succesfull; 
expression of intracellular and secreted HMFO was demonstrated 
and it was possible to convert HMF to FDCA by using whole cells or 
concentrated supernatant. Unfortunately, the expression levels were 
not competitive to the heterologous expression previously optimized 
in E. coli.
In Chapter 4, another remarkable flavoprotein oxidase was explored. 
It is the case of alcohol oxidase from Phanerochaete chrysosporium 
(AOX). This biocatalyst was recently discovered and engineered in our 
group. In the study reported in this thesis, the biocatalytic potential 
of this enzyme was further expanded. By testing a large set of poten-
tial substrates, it was discovered that the oxidase has a very relaxed 
substrate acceptance profile and intriguing catalytic properties. The 
most striking discovery was the capability of AOX to perform selective 
double oxidations of short aliphatic diols to obtain hydroxy acids or 
lactones by in situ formation of stable hemiacetals. Also, longer diols 
could be oxidized by AOX, resulting in the corresponding oxocarbox-
ylic acids through a triple oxidation. Some of the chemicals produced, 
such as γ-butyrolactone and γ-valerolactone, are valuable building 
blocks for biodegradable polymers. 
In Chapter 5, the potential of F420-dependent enzymes for ketone 
reductions was studied. A specific deazaflavoprotein alcohol dehy-
drogenase (ADF) was found to be able to reduce various prochiral 
ketones in a highly enantioselective manner. This unveils a new class 
of F420-dependent redox enzymes (alcohol dehydrogenases that can 
be used for ketone reductions) that represent alternatives to the well-
known and widely applied nicotinamide cofactor-dependent enzymes. 
The potential of this discovery is enhanced by the demonstration that 
isopropanol can be used as cheap cosubstrate for cofactor recycling, 
making ADF self-sufficient. Moreover, a semi-synthetic cofactor was 
tested as alternative to F420: FOP. Despite the low conversion rates 
in some cases (probaby due to poor recognition of FOP by ADF) the 
enantioselectivity was largely retained.
NL
Samenvatting




Het werk wat beschreven wordt in dit proefschrift focust zich op het 
bestuderen en ontwikkelen van flavo- en deazaflavoenzymen in het 
kader van biokatalyse. In de afgelopen jaren hebben bio-katalytische 
oxidaties uitgevoerd door flavine-afhankelijke enzymen grote belang-
stelling gekregen in de academische wereld en industrie. Ondanks het 
feit dat sommige flavoproteïne oxidases welbekend zijn en veelvuldig 
worden toegepast in de biotechnologie, zijn er vele flavoproteïne oxi-
dases die nog nooit overwogen zijn voor biokatalyse.
Flavine-afhankelijke oxidases zijn geclassificeerd in zes verschillende 
enzymfamilies gebaseerd op hun structurele eigenschappen, zoals 
beschreven in Hoofdstuk 1. Flavoproteïne oxidases zijn relatief ge-
makkelijk te gebruiken omdat ze voor activiteit geen additionele dure 
cofactoren of cofactor recycling systemen nodig hebben. Ze bevatten 
een sterk gebonden flavine cofactor en hebben alleen moleculaire 
zuurstof (O2) nodig als elektronenacceptor. Verschillende van deze oxi-
dases worden toegepast in de synthese van waardevolle chemicaliën 
en gebruikt in biosensoren. Meerdere oxidases van de GMC-oxidase 
familie worden in dit hoofdstuk in detail beschreven om zo een com-
pleter beeld van hun toepassingen te schetsen. Daarnaast wordt ook 
het proces en de doeleinden waarvoor deze enzymen zijn aangepast 
(engineered) toegelicht. 
In Hoofdstuk 2 wordt er gekeken naar het maken van een aangepaste 
versie van een flavine-bevattend HMF-oxidase (HMFO) voor verbe-
terde thermostabiliteit. HMFO van de bacterie Methylovorus sp. MP688 
werd in 2014 ontdekt en vertegenwoordigt een effectieve en unieke 
biokatalysator voor de productie van FDCA uit HMF. Het is het enige 
bekende enzym dat in staat is om de drievoudige oxidatie van HMF uit 
te voeren. In een eerdere studie was HMFO al geoptimaliseerd voor de 
productie van FDCA door het aanpassen van het katalytische centrum 
(active site) om zo de laatste en snelheidsbeperkende oxidatiestap te 
verbeteren. Helaas vertoonde deze geoptimaliseerde variant, ondanks 
goede katalytische prestaties, een relatief lage thermostabiliteit. Dit 
hoofdstuk beschrijft de uitgevoerde werkzaamheden die hebben 
geresulteerd in een HMFO-variant met een beduidend hogere ther-
mostabiliteit. Om meer thermostabiele enzymvarianten te genereren, 
is een recent ontwikkeld computerprotocol (FRESCO) gebruikt. Deze 
in silico methode maakt gebruik van een opgehelderde eiwitstructuur 
(in dit geval van HMFO) en voorspelt, met behulp van vrije energie 
berekeningen en moleculaire dynamica-simulaties, mutaties die het 
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eiwit meer thermostabiel zouden moeten maken. De door FRESCO 
voorspelde puntmutaties voor HMFO werden in het laboratorium 
getest, wat een aantal relatief thermostabiele mutanten opleverde. In 
een volgende stap werden de stabiliserende mutaties gecombineerd 
om een  zeer thermostabiele HMFO-variant te creëren. Om de beste 
combinatie van mutaties te identificeren, werd een nieuwe methode 
voor gene-shuffling ontwikkeld. De geïdentificeerde thermostabiele 
HMFO-variant vertoonde een smelttemperatuur die 12 °C hoger is 
dan die van het wildtype enzym. Door de mutaties die gunstig zijn 
voor het katalyseren van de laatste oxidatiestap toe te voegen, werd de 
laatste variant (8BxHMFO) verkregen. Deze geoptimaliseerde variant 
van HMFO resulteerde in significant hogere conversies van HMF naar 
FDCA.
Een andere studie om de toepasbaarheid van HMFO te verbeteren, 
wordt beschreven in Hoofdstuk 3. Het doel was om de heterologe 
expressie van het enzym te optimaliseren, waardoor de productie en 
toepassing ervan efficiënter wordt. Om dit te bereiken werden twee 
strategieën gevolgd.
De eerste aanpak om de efficiëntie van HMFO productie te verbeteren, 
was om de biokatalysator te immobiliseren met behulp van een in 
vivo systeem. Bacillus subtilis is gebruikt om HMFO op de oppervlakte 
van sporen te verankeren. Verschillende constructen zijn gemaakt 
en met behulp van CRISPR-Cas9 in het genoom aangebracht. De in-
tegratie in het genoom was efficiënt, maar voor alle gegenereerde 
varianten was er geen expressie of geen expressie van actief HMFO. 
Optimalisatie-inspanningen waren gericht op het bevorderen van 
het vouwen van HMFO door de FAD cofactor toe te voegen en op het 
optimaliseren van de behandelde sporen. Meer onderzoek is nodig 
om de oorzaak van afwezigheid van expressie/activiteit vast te stellen. 
Hoogstwaarschijnlijk veroorzaakt het verkeerd vouwen van het eiwit 
de waargenomen problemen.
De tweede aanpak om heterologe expressie van HMFO te verbeteren 
was door uitscheiding met behulp van de gist Pichia pastoris. Van P. 
pastoris is het bekend dat het in sommige gevallen een hoge productie 
van uitgescheiden eiwitten mogelijk maakt. De expressie van HMFO 
in P. pastoris werd bereikt door genomische integratie van een cassette 
met een antibioticumresistentie-gen voor selectie, een methanol- 
gereguleerde promotor en de 8BxHMFO-coderende sequentie met of 
zonder de alfa-mating factor voor secretie of intracellulaire expressie. 
Beide expressiesystemen waren succesvol; expressie van intracellu-
laire en uitgescheiden HMFO werd aangetoond en het was mogelijk 
om HMF om te zetten in FDCA door gebruik te maken van hele cellen 
of geconcentreerd supernatant. Helaas waren de expressieniveaus niet 
vergelijkbaar met de heterologe expressie die eerder al was behaald 
in Escherichia coli.
In Hoofdstuk 4 werd een ander opmerkelijke flavoproteïne oxidase 
onderzocht, namelijk het alcohol oxidase uit Phanerochaete chryso-
sporium (AOX). Deze biokatalysator is onlangs ontdekt. In de studie 
die in dit proefschrift wordt beschreven, werd het biokatalytische 
potentieel van dit enzym verder uitgebreid. Door een groot aantal 
potentiële substraten te testen, werd ontdekt dat het oxidase een zeer 
breed acceptatie profiel en intrigerende katalytische eigenschappen 
heeft. De meest opvallende ontdekking was het vermogen van AOX 
om selectieve dubbele oxidaties uit te voeren van korte alifatische 
diolen om hydroxyzuren of lactonen te verkrijgen door in situ vor-
ming van stabiele hemiacetalen. Ook konden langere diolen worden 
geoxideerd door AOX, wat resulteert in oxocarbonzuren door een 
drievoudige oxidatie. Sommige van de geproduceerde chemicaliën, 
zoals γ-butyrolacton en γ-valerolacton, zijn waardevolle bouwstenen 
voor biologisch afbreekbare polymeren.
In Hoofdstuk 5 werd het potentieel van F420-afhankelijke enzymen 
voor selectieve reductie van ketonen bestudeerd. Een specifiek dea-
zaflavoproteïne alcohol dehydrogenase (ADF) bleek in staat te zijn 
om verschillende prochirale ketonen op een enantioselectieve ma-
nier te reduceren. Dit heeft een nieuwe klasse van F420-afhankelijke 
redox- enzymen onthuld (alcohol dehydrogenases die kunnen worden 
gebruikt voor keton reductie), die alternatieven vertegenwoordigen 
voor de bekende en algemeen toegepaste nicotinamide-cofactor-af-
hankelijke enzymen. Het potentieel van deze ontdekking wordt ver-
groot door het feit dat isopropanol kan worden gebruikt als goedkoop 
cosubstraat voor cofactor-recycling, waardoor ADF zelfvoorzienend 
wordt. Bovendien werd een semi-synthetische cofactor getest als 
alternatief voor F420: FOP. Ondanks de lage conversies in sommige 
gevallen (waarschijnlijk vanwege de slechte herkenning van FOP door 
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